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Ontogenetic development of the IGF-system and leptin in offspring of sows fed 
with gestation diets differing in protein content 
The aim of this dissertation was to characterize leptin and the different components of the IGF-system 
in offspring of sows fed with different protein contents throughout pregnancy and to ascertain long 
term consequences caused by an inadequate nutritional environment in utero. German Landrace gilts 
(n=78) were fed gestation diets (~15.4 MJ ME/kg) of either low (LP, 6%; n=26), adequate (AP, 12%; 
n=26), or high (HP, 30%; n=24) protein content. For sampling at day 94 of gestation, 26 gilts with their 
fetuses were investigated. At parturition, the offspring of the remaining 52 gilts were cross fostered to 
nursing sows fed a standard lactation diet. Fetal and birth weight of all investigated offspring were 
recorded and classified into 2 different fetal body weight classes (Fbwc ≤ or > 0.65 kg) or birth weight 
classes (Bbwc ≤ or > 1.3 kg). In addition, the litter size of any gilt was classified into two groups (Lsgr 
≤ or > 12 piglets). Blood and liver samples from 306 piglets in total were collected. In detail, fetuses of 
day 94 of gestation (dpc), and piglets at their 1st, 28th and 188th day of life (dpn) were sampled. Blood 
samples were assayed for IGF-1, IGF-2 and leptin by ELISA and for IGF binding proteins via a 
quantitative, non-radioactive Western ligand blotting protocol established and optimized herein. Liver 
samples were assayed for IGF-1 receptor by use of ELISA. The concentrations of leptin in offspring 
were not affected by maternal diet over all postnatal days. With the exception of dpn 1, the IGF-1 
concentrations remained unchanged in response to maternal dietary treatment. Piglets born to 
mothers fed the LP diet had decreased IGF-1 concentrations compared to piglets born to HP mothers 
(P < 0.05). Piglets of lower birth weight also showed lower IGF-1 concentrations; IGF-1 and the body 
weights on dpn 1 were positively correlated. For IGF-2, an association between its concentration and 
low fetal body weight was observed. In line with previous studies, nutrient restriction as modulator had 
more pronounced effects on the circulating IGF-1 concentrations than the ones of IGF-2. The 
concentrations of the IGFBPs were primarily effected by nutrition in utero at the early stages of 
development. IGFBP-1 was higher in HP fetuses compared to the other two diet groups on dpc 94. 
For neonatal piglets, IGF-1 and IGFBP-1 were negatively correlated; piglets from LP fed mothers had 
higher IGFBP-1 values; they also had lower concentrations of IGF-1 than AP and HP piglets. Piglets 
born to LP fed mothers had lower IGFBP-2 values on dpn 1 and dpn 28; for IGFBP-3 differences 
related to maternal feeding group were limited to dpn 1: HP piglets had higher IGFBP-3 concentrations 
than AP piglets. On none of the sampling days, differences between the diet groups were observed for 
liver IGF-1 receptor content. Neither maternal feeding group nor fetal body weight nor litter size nor 
sex apparently influenced IGF-1 receptor content on dpc 94 in liver, indicating that different protein 
diets in utero throughout the entire pregnancy might rather act at the level of the ligand than of the 
receptor, if the IGF-system is concerned at all. Nevertheless the results of this study show clearly, that 
all ascertained effects of modified protein diets during gestation were limited to prenatal and early 
postnatal life. Significant effects resulted predominantly from protein restriction in utero whereas 
protein excess exerted no or only few effects on all factors tested. Possibly the inadequate protein 
supply during gestation could largely be compensated during the suckling period and thereafter when 
feeding was homogeneous in all groups. The lack of persistent effects by maternal feeding on the 
endocrine systems indicates adaptive processes; moreover, carcass composition data do not support 
long lasting effects of subtle early endocrine changes. 
Einfluss divergenter Proteinversorgung in utero auf die ontogenetische 
Entwicklung von Leptin und des IGF-Systems in Ferkeln 
Das Ziel dieser Studie war es, kurz- und langfristige Reaktionen auf maternales, intrauterines 
Nahrungsproteindefizit und –überschuss bei Ferkeln unterschiedlichen Alters in Hinblick auf 
verschiedene Komponenten der IGF-Achse und Leptin zu prüfen und zu charakterisieren. 
Jungsauen der Deutschen Landrasse (n=78) wurden während der gesamten Trächtigkeit mit 
isoenergetischen Diäten (~15,4 MJ ME/kg) unterschiedlichen Proteingehaltes ernährt: Niedrigprotein 
(NP, 6%; n=26), Adäquatprotein (AP, 12%; n=26) oder Hochprotein (HP, 30%; n=24). Am 94. 
Gestationstag wurden 26 Jungsauen und deren Föten untersucht. Am Tag der Geburt wurden die 
Nachkommen der verbliebenen 54 Jungsauen zu Ammensauen umgesetzt, die eine standardisierte 
Laktationsdiät bekamen. Das Körpergewicht der Föten und der neugeborenen Ferkel wurde 
festgestellt und in zwei verschiedene fötale Körpergewichtsklassen (fKgk ≤ oder > 0,65 kg) und 
Geburtsgewichtsklassen (Ggk ≤ oder > 1,35 kg) eingeteilt. Zusätzlich wurden die Wurfgruppengrößen 
klassifiziert (Wgg ≤ oder > 12). Es wurden Blut- und Leberproben von Föten des 93. Gestationstag 
(dpc) und Ferkeln des ersten, 28. und 188. Lebenstages (dpn) gesammelt (n=306). Die Blutproben 
wurden mittels ELISA auf IGF-1, IGF-2 und Leptin untersucht. Desweiteren wurden in den Blutproben 
die IGF-Bindungsproteine 1-4 (IGFBP 1-4) mit Hilfe eines quantitativen, nicht-radioaktiven Western 
Liganden Blot Protokolls gemessen, das in dieser Arbeit etabliert und optimiert wurde. Ebenfalls im 
ELISA wurden Leberproben auf den Gehalt an IGF-1 Rezeptor (IGF-1 R) untersucht. 
Die Leptinkonzentration im Blut war über alle postnatalen Tage nicht von der Diät beeinflusst. Mit der 
Ausnahme von dpn 1, blieb die IGF-1 Konzentration in Bezug auf die maternale Diät in utero 
unverändert. Ferkel von Müttern, denen die NP Diät während der Trächtigkeit gefüttert wurde, hatten 
eine niedrigere IGF-1-Konzentration im Blut im Vergleich zu den Nachkommen der HP Mütter (P < 
0,05). Ferkel mit geringerem Geburtsgewicht zeigten ebenfalls geringere IGF-1 Konzentrationen; 
IGF-1 und die Geburtsgewichte korrelierten an Tag 1 positiv. Für IGF-2 konnte eine Verbindung 
zwischen dessen Konzentration und niedrigem fötalem Körpergewicht beobachtet werden. In 
Übereinstimmung mit früheren Untersuchungen, hat Nährstoffrestriktion als Modulator stärkere und 
profiliertere Einflüsse auf die IGF-1 als auf die IGF-2-Konzentration im Blut. Die Konzentration der 
IGF-Bindungsproteine wurde hauptsächlich in der frühen Entwicklung der Nachkommen durch die 
Nährstoffversorgung in utero beeinflusst. Am dpc 94 war IGFBP-1 in HP Föten höher als in den 
Nachkommen der beiden anderen Diätgruppen. Für die neugeborenen Ferkel wurde eine negative 
Korrelation zwischen IGF-1 und dem IGFBP-1 festgestellt; Nachkommen der NP gefütterten Mütter 
hatten höhere IGFBP-1 Werte; sie hatten aber auch geringere Konzentrationen an IGF-1 im Blut, als 
die AP und HP Ferkel. An Tag 1 und Tag 28 hatten NP Ferkel niedrigere IGFBP-2 Werte; für IGFBP-3 
waren die Unterschiede aufgrund der maternalen Diät auf Tag 1 limitiert: Die Konzentration an 
IGFBP-3 war in den HP Ferkeln höher als in den AP Ferkeln. An keinem der Probennahmetage 
wurden Unterschiede in der hepatischen Konzentration des IGF-1 R in Bezug auf die Diätgruppen 
festgestellt. Weder die maternale Fütterungsgruppe, noch das fötale Körpergewicht oder das 
Geschlecht beeinflussten offensichtlich den Gehalt an IGF-1 R in der Leber an dpc 94. Diese 
Tatsache weist darauf hin, dass unterschiedliche Proteindiäten während der Trächtigkeit eher auf der 
Ebene der Liganden als auf der Ebene der Rezeptoren wirken, wenn signifikante Effekte überhaupt 
feststellbar waren. Trotzdem zeigen die Ergebnisse dieser Studie sehr deutlich, dass alle Effekte 
durch modifizierte Proteindiäten während der Trächtigkeit sich vor allem auf das pränatale und frühe 
postnatale Leben beschränken. Signifikante Unterschiede resultierten vornehmlich aus der 
Proteinrestriktion in utero, wohingegen Proteinüberschuss keine bis sehr geringe Auswirkungen auf 
alle getesteten Faktoren hatte. Möglicherweise kann die unzureichende Proteinversorgung während 
der Trächtigkeit über die Säugezeit und der anschließenden, für alle Gruppen homogenen Fütterung 
kompensiert werden. Das Fehlen von persistierenden Auswirkungen der maternalen, inadäquaten 
Ernährung während der Trächtigkeit auf das endokrine System der Nachkommen ist bezeichnend für 
adaptive Prozesse. Darüber hinaus unterstützen auch die Daten der Körperzusammensetzung keine, 
durch frühe endokrine Veränderungen hervorgerufene, anhaltende Veränderungen. 
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1 Introduction 
In domestic farm animal species such as the pig, the number of offspring, their 
growth rate, feed efficiency and stress resistance are important economic traits. Pig 
farmers ask for healthy and normal weight piglets preferable with consistent genetics, 
which will yield carcasses as requested from the market, by efficient feed conversion. 
Reduced survival and compromised postnatal development due to low birth weight 
imply economic losses for the pig industry (Litten et al., 2003). Low birth weight 
piglets have low-grade productivity such as depressed growth and lower carcass and 
meat quality (Rehfeldt and Kuhn, 2006; Rehfeldt et al., 2008).  
For achieving the required traits, it is important to have optimal environmental 
conditions in pig production and breeding. The literature indicates that a considerable 
amount of the variation in postnatal growth performance may largely be determined, 
and essentially be preprogrammed, during the fetal development in uterus (Foxcroft 
et al., 2006). A lot of intrauterine environmental factors affecting the conceptus such 
as maternal stress, energy supply, hypoxia and placental insufficiency; and dietary 
manipulation may alter the expression of the fetal genome with lifelong 
consequences. The present thesis will focus on the impact of the nutritional 
environment in utero on endocrine hormones, in particular on the insulin-like growth 
factor system, in the progeny as forwarded by maternal protein supply during 
gestation. 
1.1 Fetal programming 
The notion that environmental factors, particularly nutrition, act in early life to 
program the risk for the early onset of cardiovascular and metabolic disease in adult 
life and premature death was expressed by David Barker (1990) as the hypothesis of 
the ‘early’ or ‘fetal’ origins of adult disease. Series of worldwide epidemiological 
studies in humans and animals were following and they extended the initial 
observations with the association between pre- and postnatal growth and 
cardiovascular disease and included associations between early growth patterns and 
an increased risk for hypertension, impaired glucose tolerance, non-insulin-
dependent or type 2 diabetes, insulin resistance, and obesity in adult life (McMillen 
and Robinson, 2005). To explain the biological basis of the association observed 
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between birth weight and health outcomes in later life, a number of outlines have 
been proposed. One of them was the ‘Thrifty Phenotype Hypothesis’ of Hales and 
Barker (1992) suggesting that a poor environment in utero will initiate an adaptive 
response which optimizes the growth of key body organs to the disadvantage of 
others and thereby leads to alterations in postnatal metabolism in order to support 
postnatal survival under conditions of malnourishment. These adaptations only 
become adverse in case of abundant postnatal nutrition following the supply 
experienced in utero (Hales and Barker, 1992). The idea that there are embryonic 
and fetal adaptations to a suboptimal intrauterine environment which result in 
permanent adverse consequences is in line with the definition of ‘programming’ by 
Lucas in 1991 (Lucas, 2007). Programming has been defined as ‘the induction, 
deletion, or impaired development of a permanent somatic structure or the “setting” 
of a physiological system by an early stimulus or insult operating at a “sensitive” 
period, resulting in long term consequences for function’ (Lucas, 2007). Intrauterine 
programming can occur at any level within the affected physiological system and may 
involve structural and functional changes in genes, cell tissues, and even entire 
organs. These changes may be isolated or widespread events with either discrete or 
cumulative effects on development depending on the nature and timing of the 
programming stimulus (McMillen and Robinson, 2005). 
1.2 Intrauterine growth restriction (IUGR) and fetal programming in 
farm animals 
Considerable effort has been directed towards defining nutrient requirements of 
animals over the past 30 years, because suboptimal nutrition during gestation 
remains a significant problem for many animal species such as cattle, sheep and 
pigs worldwide (Bell and Ehrhardt, 2002). Overnutrition, as an inadequate form of 
nutrition, can result from an increased intake of energy and/or protein. Extensive 
studies have shown that maternal overnutrition retards placental and fetal growth, 
and increases fetal and neonatal mortality in rats, sheep and pigs (Wallace et al., 
2003). In contrast, maternal undernutrition during gestation reduces placental and 
fetal growth both in domestic farm animals and in humans (Barker and Clark, 1997; 
Bell and Ehrhardt, 2002). In livestock species, fetal undernutrition frequently occurs 
worldwide (Wu et al., 2004). Due to the fact that nutritional and developmental 
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research often involves invasive tissue collections and surgical procedures, it is 
neither ethical nor practical to conduct such experiments in pregnant women and 
their children. Therefore, animal models such as mice, rats, sheep and pigs are 
appropriate for defining the mechanisms of intrauterine growth retardation (IUGR) 
resulting in lighter birth weight and fetal programming (Wu et al., 2006). The pig 
model has the advantage that there is a great similarity in organ size, physiology, 
metabolism and also genetics in comparison to man (Du et al., 2007). Accordingly, it 
is an appropriate model to design experiments dealing with both birth weight and 
prenatal as well as neonatal nutrient supply. In sows fed in line with demand, an up 
to 3-fold difference in body weight among littermates may occur, thus providing a 
natural form of IUGR (Morise et al., 2008). Low birth weights naturally occur in this 
polytocous species, in conjunction with intrauterine crowding and increasing litter size 
(Milligan et al., 2002; Town et al., 2004). Nevertheless, there are factors e.g., limited 
oxygen and nutrient supply, which mainly lead to IUGR via impaired placental 
function (Rehfeldt et al., 2010). Induction of IUGR, resulting in lighter birth weight, is 
a significant problem in pig production (Wu et al., 2006).  
Over the past decade, compelling epidemiological studies have linked IUGR with the 
etiology of many chronic diseases in adult humans and animals (Barker and Clark, 
1997). Extensive animal studies motivated the identification of the biochemical basis 
for nutritional programming of fetal development and its long-term health 
consequences (Wu et al., 2004). IUGR can be initiated by maternal stress, hypoxia, 
glucocorticoid administration, dietary manipulation or placental insufficiency and 
leads to postnatal abnormalities in cardiovascular, metabolic, and endocrine function 
in diverse animals including primates and pigs (McMillen and Robinson, 2005). In 
addition to effects of fetal retardation due to poor intrauterine maternal nutrition, it is 
known that constitution and catch up of nutrition from birth till weaning can exert 
permanent impacts on performance and health of farm animals (Kim et al., 2004; 
Foote et al., 2007; Khan et al., 2007). However, it is not entirely clarified how these 
immediate measurable effects will influence animal performance, health and well-
being, and product quality in the long term. 
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1.3 Programming and related endocrine metabolites and systems 
Many metabolic disorders have an endocrine origin and are accompanied by 
abnormal hormone concentrations. Hormones have an important role in regulating 
normal growth and development in utero, and their concentrations and bioactivity 
change in response to many of the environmental challenges known to cause 
intrauterine programming (Fowden and Forhead, 2004). Associated to the hormonal 
factors, the insulin-like growth factor system seems of major importance (Davis, 
1988; Humbel, 1990; Isaksson et al., 1990). This system is a fundamental part of the 
somatotropic axis as schematically shown in Figure 1.  
 
 
Figure 1: The somatotropic axis: The secretion of growth hormone (GH) from the pituitary is 
primarily regulated by two hypothalamic neurohormones: a stimulatory hormone, the GH-
releasing hormone (GH-RH) and the GH-inhibiting hormone (GH-IH). Different environmental 
and internal stimuli e.g. physical exertion, fasting, stress, content of nutrients in blood and 
low plasma glucose concentrations enhance the secretion of GH from the pituitary. The 
ability of GH to increase the secretion of insulin-like growth factor-1 (IGF-1) from the liver has 
anabolic consequences on target tissues. Indeed IGF-1 exerts negative feedback control on 
the secretion of GH by actions both on the pituitary gland and the hypothalamus. In addition 
to the anabolic growth-stimulating action via IGF-1, GH itself affects lipid metabolism in a 
catabolic way by stimulating lipolysis in adipose tissue. In states of sufficient nutrient supply 
the switch from GH to IGF-1 is alleviated whereas in situations of deficient nutrient supply, 
the stimulatory effect of GH on IGF-1 is compromised, albeit the GH concentrations during 
fasting are elevated (adapted from Breier and Sauerwein, 1995). 
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Expression of the insulin-like growth factors 1 and 2 (IGF-1 and IGF-2), IGF binding 
proteins (IGFBPs) and receptors for the IGFs (IGF1R and IGF2R) is controlled by the 
nutritional and the hormonal environment in utero (Fowden et al., 2005). The 
concentrations of the IGF proteins in the fetus are positively correlated with birth 
weight in several species including humans, sheep, rodents and pigs (Daughaday et 
al., 1982; Gluckman and Butler, 1983; Lee et al., 1993; Ong et al., 2000). Changes in 
the circulating concentrations of fetal IGFs and IGFBPs may cause alterations in 
development and growth of various fetal tissues. Thus, if differences in maternal 
feeding level affect the nutrient supply to the fetus/or the fetal concentration of the 
IGFs and IGFBPs, overall fetal growth and birth weight will be affected (Rehfeldt et 
al., 2010). Accordingly, the utilization and partitioning of nutrients are controlled by 
hormones and growth factors but, contrariwise, the hormonal status can also be 
influenced by nutrition (Thissen et al., 1994). In the pig, the role and the 
developmental control of the IGF-system in the fetus is not manifested (Fowden, 
2003). Impaired or altered bodily functions or performance in adulthood initiated by 
inadequate nutrient supply during intra-uterine life suggest the notion of a ‘diet 
memory’ inscribing the altered information to be executed at later stages of 
ontogenesis. For the IGF-system, only few follow-up studies on the effects of 
intrauterine compromises have been conducted.  
Numerous studies in humans and in various animal species have established that 
intrauterine growth retarded newborns show an increased susceptibility to develop 
obesity and metabolic syndrome when submitted to high caloric diets in adult life. It 
has also been shown in several studies that the evolution of leptin, a basic hormone 
of the lipid metabolism which is mainly produced in adipocytes, is imbalanced in 
IUGR during late gestation and early postnatal life. Hence it has been suggested that 
leptin deficiency in IUGR participates in inducing improper programming (Djiane and 
Attig, 2008). Recent studies showed that plasma leptin concentrations are low in 
growth-restricted infants at birth (Jaquet et al., 1998). Besides, a negative correlation 
between body weight at birth and subsequent expression of leptin was shown in pigs 
(Eckert et al., 2000). In the last decades, several serum proteins and hormones have 
been strongly related to fetal growth. Albeit the control of growth in the fetus and 
neonate is complex, the insulin-like growth factors (Giudice et al., 1995; Holmes et 
al., 1997; Klauwer et al., 1997) and leptin (Harigaya et al., 1997; Ertl et al., 1999) in 
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particular have been shown to play important roles in mediating fetal and postnatal 
growth and development as well as being related to nutritional status (Lo et al., 
2002). The IGF-system and leptin seem to be reciprocally associated. At the central 
level, leptin stimulates the secretion of GH; in consequence, GH also appears to 
have a negative feedback loop with leptin (Quintela et al., 1997; Cocchi et al., 1999). 
Studies performed in vivo in rats and in pigs have clearly demonstrated this 
stimulatory effect (Tannenbaum et al., 1998; Ramsay et al., 2004). Interestingly, as 
the IGF-system is known to be deficient in the case of IUGR (Woodall et al., 1996), it 
can be speculated that leptin’s actions on body and organ growth are mediated by 
stimulation of the IGF-system. Taken together, the growth-promoting effects of leptin 
appear to be complex, involving at least central and peripheral actions (Djiane and 
Attig, 2008). Production and excretion of leptin in adipocytes are probably maintained 
through direct (autocrine and/or paracrine) negative feedback signals (Zhang et al., 
1997), as well as by other hormones, many of which are also regulated by leptin 
(Reidy and Weber, 2000). A major outcome of GH stimulation is the increased 
production of IGF-I, and several anabolic actions of GH are mediated through IGF-1 
(Heiman et al., 1999). Changes in circulating IGF-1 concentrations are positively 
correlated with changes in blood leptin levels (Heiman et al., 1999). Leptin has a key 
role in energy homeostasis and there may be a link between leptin and the IGF-
system. Experimental models have provided evidence of leptin functioning as a 
neuromodulator of the GH-IGF axis by connecting this hormonal system with 
nutritional status (LaPaglia et al., 1998). 
1.3.1 The IGF-System 
Insulin-like growth factors (IGF-1 and IGF-2) are single chain polypeptides, highly 
homologous with low molecular weight (7.6 and 7.5 kDa, respectively) that are 
structurally similar to pro-insulin. Unlike insulin, they are produced by most tissues of 
the body and are abundant in the circulation. IGF-1 and IGF-2 both act as mitogens 
and are also involved in differentiation and apoptosis of a multitude of cell types 
(Cohick and Clemmons, 1993). They regulate cell proliferation in an interconnected 
action via autocrine, paracrine and endocrine regulatory mechanisms (Pavelic et al., 
2007). Complementary to their effects on cell proliferation, the IGFs can also inhibit 
cell death (Jones and Clemmons, 1995). Their effects are mediated through the IGF-
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1 receptor (IGF-1R) which initiates signaling cascades that result in regulation of a 
number of biological responses (Figure 2).  
Figure 2: The IGF-System with the Insulin-like growth factors (IGF-1 and IGF-2), their 
receptors type-1 (IGF-1R) and type 2 (IGF-2R) and their binding proteins (IGFBPs 1-6). 
ALS= acid labile subunit (modified from Randhawa and Cohen, 2005) 
 
The IGF-1R is very similar to the insulin receptor (IR). They are both classic 
membrane-bound tyrosine kinase receptors. Structurally, they are heterotetramers, 
consisting of two identical extracellular α subunits (which bind to the ligand) and two 
transmembrane β subunits (which trigger an intracellular kinase signaling cascade in 
response to ligand binding) (Jones and Clemmons, 1995; Pollak et al., 2004). Hybrid 
receptors formed out of IGF-1R and IR can bind IGF-1, IGF-2 and insulin with 
differing affinity (Jones and Clemmons, 1995). There is a high similarity in structure 
between the IR and IGF-1R, and between insulin and the IGFs, which allows for low-
affinity binding of IGFs to IR and similar for low-affinity cross-binding of insulin to IGF-
1R. The structurally dissimilar type-2 IGF Receptor also known as mannose-6-
phosphate receptor (IGF-2R/M6PR) is involved in binding, initialization and 
degradation of IGF-2 (Pavelic et al., 2007). IGF-2R has no known intracellular kinase 
signaling domain (Kelley et al., 2002) and achieves no known IGF signaling function 
(Jones and Clemmons, 1995). The IGFs present in the circulation and throughout the 
extracellular space are almost entirely bound to members of a family of high affinity 
IGF binding proteins (IGFBPs). There are six of these binding proteins (IGFBP 1-6) 
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that specifically bind and modulate the mitogenic/metabolic actions of the IGFs. Four 
of the IGFBPs (IGFBP 1-4) are found in serum in significant quantities (Zapf et al., 
1990). Most of the IGFs in the bloodstream (75-80%) form part of a 150 kDa complex 
containing IGF-1 or IGF-2, IGFBP-3 and an acid labile subunit (ALS). The remaining 
20-25% of IGFs are associated with one of the other IGFBPs in a binary complex. 
Less than 1% of the IGFs is present in the free form (Gicquel and Le Bouc, 2006). 
The IGFBPs can have a higher or lower affinity for IGFs than the IGF receptor and, 
therefore, provide several regulatory functions. These functions include associating 
IGFs (effectively inhibiting function), prolonging the circulating half life, providing a 
circulating storage reservoir, and locally concentrating the IGFs, many of which 
effectively increase the function of the IGFs (Bowman et al., 2010). Stimulatory as 
well as inhibitory effects of IGFBPs on IGF actions have been described. In addition, 
IGF-independent effects of several IGFBPs are emerging (Jones and Clemmons 
1995). Accumulating evidence indicates important roles for members of the IGFBP 
family in metabolic homeostasis as recently reviewed by Wheatcroft and Kearney 
(2009). 
1.3.1.1 Interrelation between IGF-1 and nutrition 
Under common physiological conditions, the main regulatory factor influencing the 
synthesis and secretion of IGF-1 is GH (Figure 1) (Buonomo and Baile, 1991). The 
stimulatory effect of GH on serum concentrations of IGF-1 is mediated by direct 
effects on IGF-1 synthesis, and through the synthesis of the components of the large 
150 kDa ternary complex of IGF-1 and IGFBP-3 with the acid labile subunit (Thissen 
et al., 1994). Insulin-like growth factor 1 is an endocrine factor, mainly secreted from 
the liver in response to GH stimulation. It mediates the effects of GH in peripheral 
tissues (Breier, 1999). The rate of IGF-1 synthesis in tissue and its secretion into the 
systemic circulation is dependent not only upon pituitary GH but also upon nutrient 
availability and metabolic hormone status (Buonomo and Baile, 1991; Clemmons and 
Underwood, 1991). Control of IGF synthesis and secretion therefore may provide an 
intermediate signaling mechanism that designates to target cells that adequate 
nutrients have been ingested and are available for cell division and protein synthesis 
(Clemmons and Underwood, 1991). Acute feed restriction, general nutrient deficiency 
and periods of insufficient protein intake cause a decline of basal circulating 
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concentrations of IGF-1 due to reduced IGF-1 gene expression (Buonomo and Baile, 
1991; Thissen et al., 1994; Breier, 1999). This explains for the dependency of IGF-1 
plasma concentrations of nutritional status (Breier et al., 1986). The IGFs appear to 
provide an important mechanism linking nutrition and growth (Thissen et al., 1994). 
To understand the role of the IGFs in mediating the effects of nutrient intake on 
anabolic responses, it is important to realize that IGFs may function as 
autocrine/paracrine growth factors as well as classic endocrine hormones 
(Clemmons and Underwood, 1991). The observation that the IGFs have the potential 
to fulfill an important role as mediators of tissue anabolism and stimulate both amino 
acid transport and protein synthesis in skeletal tissue, supports the concept of 
nutrient-dependent growth signaling (Clemmons and Underwood, 1991). The 
availability of dietary protein is one main critical regulator of IGF-1. Dietary protein 
supply seems to be the limiting factor for maximal stimulation of IGF-1 plasma 
concentration (Breier, 1999). At early stages of development, serum IGF-1 
concentrations are critically dependent on dietary protein supply, however this protein 
dependence decreases with age (Fliesen et al., 1989). Protein deficiency lowers 
serum IGF-1 concentrations in response to GH and also produces refractoriness to 
IGF-1 action (Clemmons and Underwood, 1991). Interestingly, protein-deficient rats 
infused with IGF-1 increased their serum IGFBP-3 concentrations, suggesting that 
some actions of IGF-1 were not impaired (Hirschberg and Kopple, 1989). 
Nutritional status as well as supply of dietary energy and protein is a critical regulator 
of IGFs and IGFBPs. Diet restriction increases the clearance and degradation of 
serum IGF-1 through changes in the levels of circulating IGFBPs. More recent 
observations demonstrate that nutrients may also control the biological action of IGF-
1 either directly or indirectly through changes in IGFBPs (Thissen et al., 1994). 
1.3.1.2 Interrelation between IGF-2 and nutrition  
Both IGF-1 and IGF-2 are expressed in fetal tissues from the earliest stage of pre-
implantation to the final phase of tissue maturation before birth. IGF-2 is the primary 
growth factor supporting embryonic growth, with raising importance of IGF-1 later in 
gestation (Gicquel and Le Bouc, 2006). IGF-2 is a polypeptide which exhibits 62% 
homology with IGF-1 and 41% homology with insulin (Rinderknecht and Humbel, 
1978). Dependent on the species, serum IGF-2 concentrations are much higher than 
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IGF-1 concentrations in late gestation (Fowden, 2003). In rats and sheep, IGF-2 
levels are high during fetal life and decrease immediately after birth (Moses et al., 
1980; Mesiano et al., 1989), whereas in humans, IGF-2 levels increase after birth 
(Zapf et al., 1981). It is unclear why in spite of evolutionary conservation of this 
peptide, developmental patterns of serum IGF-2 levels are widely variable among 
mammalian species (Lee et al., 1991). Research in the area of IGF-2 has 
concentrated on its role as a fetal growth factor (Moses et al., 1980; Daughaday et 
al., 1982; Gluckman and Butler, 1983). However, in adult humans serum IGF-2 levels 
are at least four-fold higher than IGF-1 (Zapf et al., 1980) indicating that IGF-2 may 
be involved in more than fetal development. In pigs, the preponderance of IGF-2 over 
IGF-1 in fetal serum and the postnatal increases in serum levels of both IGFs also 
support the view that IGF-2 is both a fetal and a postnatal growth factor, whereas 
IGF-1 may be primarily a postnatal growth factor in pigs (Lee et al., 1991). For this 
reason both IGF-1 and IGF-2 play important but different roles in growth regulation 
(Owens et al., 1999). Like IGF-1, IGF-2 has a variety of metabolic and growth-
promoting actions in vitro that are mediated through IGF-1R (Rechler and Nissley, 
1985; Humbel, 1990; Sara and Hall, 1990). Post natum, IGF-2 is cleared via 
preferential binding to the type-2 receptor (Nielsen, 1992). 
Some of the metabolic, growth-promoting and through nutrition initiated actions of 
IGF-2 are described in the following. During fetal development, IGF-2 stimulates 
myoblast proliferation and differentiation in a dose dependant manner, as well as 
IGF-1 does (Florini et al., 1986). Observational research of Owens et al. (1999) 
suggests that androgens and estrogens may postnataly suppress circulating IGF-2 
concentrations in pigs, because the concentrations of plasma IGF-2 were similar in 
boars and in gilts but were higher in barrows than in intact animals. In addition, 
Owens et al. (1999) determined a positive association between IGF-2 and backfat 
depth in pigs. Moreover, plasma IGF-2 concentrations were increased by genetic 
selection for increased backfat depth in pigs (Buonomo and Klindt, 1993). These 
findings indicate that IGF-2 may regulate fat deposition (Owens et al., 1999). Lee et 
al. (1993) hypothesized that adipose growth might be promoted by IGF-2 originating 
from either liver, muscle, lung, or kidney and indeed, Owens et al. (1999) verified 
evidence that IGF-2 might be produced by fat tissue, which would result in higher 
IGF-2 concentrations in plasma from animals with more fat. Nutrient restriction as 
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modulator has more pronounced effects on circulating concentrations of IGF-1 than 
IGF-2, irrespective of the cause or nature of the nutrient deficit (Fowden, 2003). This 
was independently approved by Gluckman and Pinal (2003). They asserted that the 
IGF1 gene transcription is more sensitive to changes in nutritional status in late 
gestation than the IGF2 gene (Gluckman and Pinal, 2003). Moreover, serum IGF-2 
concentrations are reduced in humans following nutritional deprivation (DeHoff et al., 
1986; Buonomo et al., 1987). Following an acute fast, IGF-2 plasma concentrations 
were depressed in mature swine (Buonomo et al., 1988). Changes to maternal 
protein intake during the first and the second trimester of gestation affected IGF-2 
protein and IGF-2 mRNA expression and altered fetal and hence postnatal muscle 
development (Micke et al., 2011). However, most studies have found no association 
between serum IGF-2 concentrations and fetal weight (Fowden, 2003). 
In conclusion, the role of IGF-2 is not completely understood. Possibly, IGF-2 
modulates nutritional effects indirectly. Insulin-like growth factor-2 has the structural 
requirements that are necessary to stimulate growth. Its concentrations in plasma are 
much less dependent on GH than are the IGF-1 concentrations, and its role in 
mediating changes in the anabolic response to nutrient intake is unknown 
(Clemmons and Underwood, 1991). 
1.3.1.3 IGFBPs and nutritional regulation 
The insulin-like growth factor binding proteins are soluble carrier proteins that 
circulate in blood and extracellular fluids and appear to control IGF transport, efflux 
from the vascular compartment, and association of IGF with cell surface receptors 
(Martin and Baxter, 1992). All IGFBPs have cysteine-rich regions which are highly 
conserved and correspond to the IGF binding site. Some IGFBPs, for example 
IGFBP-3, are extensively glycosilated, whereas others are not. The IGFBPs vary 
considerable in size, glycosylation and phosphorylation states, and protease 
sensitivity (Jones and Clemmons, 1995; Hwa et al., 1999). Each of the IGFBPs could 
have an exclusive role as modulator of IGF action and the different IGFBPs seem to 
be under independent endocrine and metabolic regulation. Changes in the 
production of IGFBPs may initiate tissue-specific targeting and distribution of IGFs. 
Suggesting that they have different, regulated functions in the development of 
specific tissues, each IGFBP has unique tissue-specific and developmental stage-
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specific patterns of expression (Jones and Clemmons, 1995; Hwa et al., 1999). In 
addition, either systemic or locally produced IGFBPs alter the distribution of 
circulating IGFs within target tissues by modifying receptor-IGF interactions (Breier, 
1999).  
The IGFBPs bind to IGF-1 or IGF-2 with high but different affinity: IGFBP-2 has a 
threefold greater affinity for IGF-2. However, IGFBP-1 binds IGF-1 and -2 with 
approximately equal affinity (Rajaram et al., 1997). IGFBP-3 is a glycoprotein 
associating with ALS in serum and with IGFs to form a 150 kDa complex. This 
complex apparently prevents rapid efflux of IGF-1 and -2 from the vascular 
compartment and stabilizes the concentrations of IGFs in blood. When associated 
with the 150 kDa complex, the IGFs do not readily leave the vascular compartment, 
and their half lives are prolonged to 12-15 h (Guler et al., 1989). This contrasts with 
the half life of free binding proteins in plasma, which has been estimated to be 
between 30 and 90 minutes (Zapf et al., 1986) and the half life of free IGF-1, which is 
estimated at less than 10 min, similar to insulin (Hodgkinson et al., 1989). The 
primary function of IGFBP-3 may be to act as a carrier of IGFs in the circulation, 
whereas the primary functions of IGFBP-1 and IGFBP-2 may be to transport IGF 
across the endothelial surface to specific cell types (Bar et al., 1990). In contrast to 
IGFBP-1, -2 and -3, IGFBP-4 appears to inhibit IGF actions under most, if not all, 
experimental conditions. It binds both IGFs with equal affinity and does not appear to 
adhere to cell surfaces (Jones and Clemmons, 1995). Its main function is to protect 
cells from overstimulation by IGFs or to allow activation of alternate transmembrane 
signaling pathways that are inhibited by IGF exposure (Jones and Clemmons, 1995). 
The amount of IGFBP-5 and -6 in rats or human blood is extremely low and is 
unlikely to be of physiological significance. Both IGFBPs prefer to bind IGF-2 in 
comparison to IGF-1 (Rajaram et al., 1997). Similar to IGFBP-3, the cell surface 
association of IGFBP-5 may also mediate its ability to potentiate IGF actions. The 
lowering of IGF binding affinity, by association to the extracellular matrix or cell 
surface association is an important factor in regulating the ability of IGFBP-5 to bind 
IGF-2 (Jones and Clemmons, 1995). Studies of IGFBP-6 are limited.  
The IGFBPs 1 to 4 are the most prevalent IGFBPs in fetal plasma and tissue, 
although their relative assemblage varies both within and between species. Fetal 
expression of these IGFBPs is also tissue specific and developmentally regulated 
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(Donovan et al., 1989; Lee et al., 1993; Carr et al., 1995; Tarantal and Gargosky, 
1995). IGFBP expression in the fetus is affected by both the nutritional and endocrine 
conditions in utero. Generally, these conditions have more obvious effects on IGFBP-
1, -2 and -4 than on IGFBP-3 (Fowden, 2003). 
If the binding proteins serve different functions, it is reasonable to presume that 
regulation of their secretion may be different. For example, GH and IGF-1 both 
induce the synthesis and secretion of IGFBP-3, and increase its concentration in 
plasma (Clemmons et al., 1989). In contrast, IGFBP-1 and -2 are both suppressed by 
GH (Hardouin et al., 1989), and IGF-1 directly stimulates the secretion of IGFBP-2, 
whereas it often inhibits IGFBP-1 (Thraikill et al., 1990). 
A major regulator of circulating IGFBPs is nutrient intake. Significant reduction in 
serum IGFBP-3 concentrations is caused through extended fasting and/or protein 
deficiency (Clemmons et al., 1989), whereas acute changes in nutrient intake do not 
affect IGFBP3. Its plasma concentrations remain stable throughout the day (Baxter 
and Martin, 1989). The fact that IGFBP-3 is the major carrier of IGF-1 probably 
accounts for the stability of IGF-1 in blood (Clemmons and Underwood, 1991). 
The growth factors IGF-1 and IGF-2 and their binding proteins appear to be major 
links between nutrient intake and cellular anabolic response (Clemmons and 
Underwood, 1991). It is documented that nutrition can markedly affect the relative 
amounts and ratio of circulating IGF-1 and IGF-2. Such changes would be predicted 
to influence the serum half lives of the IGFs, the relative partitioning of IGF, IGFBP 
and IGF: IGFBP complexes between the bloodstream and extra vascular and cellular 
compartments. In addition, the bioavailability and bioactivity of circulating as well as 
of locally synthesized IGF and IGFBP would be modified. These alterations may 
affect overall somatic growth as well as the mitotic activity and differentiation state of 
target cells in a tissue specific fashion (Simmen et al., 1998). 
1.3.1.4 Functions of the IGF-1 and -2 receptors 
The biological effects of IGF-1 and IGF-2 on a target cell are mediated by two types 
of cell surface receptors: IGF receptor type 1 (IGF-1R) and IGF receptor type 2 (IGF-
2R), as well as through binding to receptors for insulin (Pavelic et al., 2007). On most 
cell types IGF-1R and IGF-2R coexist and, on many cells, insulin receptors are also 
present (Humbel, 1990).  
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In general, most of the actions of the IGFs are forwarded via the IGF-1R (Pollak et 
al., 2004) which belongs to the tyrosine-kinase class of growth factor receptors, as 
well as the insulin receptor. The IGF-1R is a glycosylated heterotetramer, consisting 
of two α- (ligand binding) subunits (135 kDa), and two transmembrane β-subunits (90 
kDa) linked by disulfide bonds, which contain a tyrosine kinase domain activating the 
receptor by autophosphorylation (Kasuga et al., 1981; Massagué and Czech, 1982). 
Ligand binding (IGF-1 or IGF-2) to the extracellular part of IGF - 1R instigates 
cytoplasmatic signal cascades that contain receptor conformational changes which 
enables them to bind adenosine-5’-triphosphate (ATP) and become 
autophosphorylated within the β-subunits, resulting in activation of the intrinsic 
tyrosine kinase activity of IGF-1R and subsequent tyrosine phosphorylation of 
several substrates. This stimulates downstream signaling through intracellular 
networks that regulate cell proliferation and survival. The activation of the intracellular 
networks results in a variety of responses, such as cell proliferation, differentiation, 
migration and protection from apoptosis (Pavelic et al., 2007). 
Recent data have shown that both the insulin and the IGF-1R can mediate metabolic 
and mitogenic responses to either ligand (Humbel, 1990). In most cells there are 
different relative binding affinities for insulin receptor: insulin >> IGF-2 > IGF-1 and 
IGF-1R: IGF-1 > IGF-2 >> insulin (Humbel, 1990). The physiological roles of both 
insulin and IGF-1 are therefore likely to be determined by the distribution and 
abundance of their receptors on the cell surface (Cohick and Clemmons, 1993). The 
fact that insulin at supraphysiological concentrations is mitogenic and that IGF at 
supraphysiological concentrations shows insulin-like metabolic effects indicates that 
metabolic effects are mediated via the insulin receptor and mitogenic effects via the 
IGF-1R, whereas the biological significance of the IGF-2R remains unclear (King et 
al., 1980). 
The IGF-2R is also known as cation-independent mannose-6-phosphate receptor 
(IGF-2R/M-6-PR) and is structurally as well as functionally different from the IGF-1R. 
The receptor is a monomeric membrane spanning glycoprotein of 250 kDa, with a 
large extracellular domain without autokinase activity (Kasuga et al., 1981; Massagué 
and Czech, 1982), which binds M-6-R, lysosomal enzymes and IGF-2 (Kornfeld, 
1992). Finally, the actions of the IGF-2R in IGF-2 signaling are less clear, while it is 
known that the receptor prefers to bind IGF-2 in comparison to IGF-1 (insulin does 
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not bind) and that IGF-2R can clearly mediate uptake and degradation of IGF-2 
(Humbel, 1990; Jones and Clemmons, 1995). The IGF-2R is present in fetal tissues 
throughout gestation and seems to be developmentally regulated during bovine fetal 
life (Pfuender et al., 1995). 
Some tissues and cell types express receptors composed of one IGF-1 receptor 
alpha and beta subunit and one insulin receptor alpha and beta subunit, defined as 
IGF-1 insulin receptor hybrids (Cohick and Clemmons, 1993). The ligand specificity 
profiles of these receptors are more comparable to the IGF-1 receptor than to the 
insulin receptor (Jones and Clemmons, 1995) which leads to a higher affinity for IGF-
1 than insulin. Hence, to induce a conformational change in the receptor and to 
activate autophosphorylation, IGF-1 is more effective than insulin (Moxham et al., 
1989; Soos et al., 1990). For most systems, the amounts to which hybrid receptors 
constitute the total receptor population has not been defined. However, there are 
some tissues, where 70% of receptors are estimated to be hybrids, e.g. the placenta 
(Soos and Siddle, 1989). This suggests that in some tissues these receptors may 
play an important role in coordinating IGF action.  
1.3.2 Leptin and its functions of a nutrient sensor 
Leptin was the first adipokine identified, i.e. it was the first signaling molecule found 
to be secreted from white adipose tissue (Zhang et al., 1994). Since then several 
other cytokines and hormones have been classified as adipokines as recently 
reviewed by Deng and Scherer (2010). Leptin (from the greek leptos, meaning thin) 
is a 16 kDa polypeptide circulating as a 146 amino acid peptide in serum. This 
hormone is primarily produced by adipose tissue as a four-helix bundle cytokine. The 
rate of leptin secretion and its plasma concentration are positively correlated with 
total fat mass (Hamilton et al., 1995; Houseknecht and Portocarrero, 1998; 
Wajchenberg, 2000; Fain et al., 2004). Thus leptin circulates as an internal signal 
indicating the size of body fat stores (Reidy and Weber, 2000). It is a circulating 
endocrine hormone, capable of communicating information from the periphery to the 
central nervous system (CNS) (Coleman, 1973) by acting through numerous 
isoforms of its receptor. Leptin receptors (LRs) are members of the cytokine 
receptors class I superfamily and are expressed in both the CNS and the periphery 
(Bjorbaek and Kahn, 2004). The LR family comprises at least 6 receptor isoforms 
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that arise due to alternative splicing and are found in different tissues throughout the 
body with different levels of expression (Reidy and Weber, 2000). The isoforms 
include a long form receptor and several short forms (Tartaglia, 1997). The effects at 
the hypothalamic level are mediated through the long form of the LR which is 
predominantly expressed there and exerts a pivotal role in the regulation of food 
intake. The short form of the LR is the dominant form in the peripheral organs (e.g. 
ovary, testis, prostate and placenta etc.) and its biological effects concern the 
modulation of cell proliferation and cell differentiation in adipose tissue, pancreas, 
stomach, liver, kidney, arteries and immune cells (Margetic et al., 2002; Myers, 
2004). The discovery of expression of several functional leptin receptors isoforms in 
CNS as well as in peripheral tissues indicates a role of leptin in an impressive list of 
biological functions as for example in lipid and energy metabolism (Tartaglia et al., 
1995), nutrient partitioning, food intake and appetite regulation, immunologic 
processes as well as reproduction and growth (Cunningham et al., 1999; Barb et al., 
2001) which are summarized in Figure 3. 
Recent studies focused on the fundamental role of leptin as a `lipostat` in regulating 
body weight. Leptin thus plays a major role in energy balance and lipid metabolism 
(Reidy and Weber, 2000). It is able to mediate lipid metabolism by central and 
peripheral ways with many different routes. Leptin regulates lipid storage in 
adipocytes as well as in skeletal muscle, liver and pancreas and adjusts lipogenesis 
and fatty acid oxidation (Houseknecht and Spurlock, 2003). The effects of leptin 
result in decreased triacylglycerol synthesis and increased lipolytic rates (Reidy and 
Weber, 2000). Leptin also mediates lipid metabolism indirectly by reducing the 
lipogenic effects of insulin, probably due to the inhibitory effect leptin exerts on the 
binding of insulin to adipocytes (Walder et al., 1997). Insulin has the exact opposite 
effect in comparison to leptin, i.e., it is depressing fatty acid oxidation and increasing 
triacylglycerol synthesis (Muoio et al., 1997). Interestingly, in addition to the inhibition 
of lipogenesis by leptin, there is reported evidence supporting a role for leptin in the 
inhibition of adipose cell proliferation (Thomas et al., 1999). In addition leptin seems 
to reduce adipose tissue mass not only by affecting feed intake via the central 
nervous system but also by inducing adipocyte apoptosis (Reidy and Weber, 2000).  
Besides adipose tissue, the mammary gland is able to produce leptin, particularly 
during the early phase of lactation. In addition, the mammary gland is involved in the 
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transport of leptin from the mother to the milk which is in fact an additional source of 
leptin for the newborn (Uysal et al., 2002). 
 
Figure 3: Schematic drawing of leptin coordinating energy homeostasis and neuroendocrine 
function. Leptin is secreted by adipose tissue and acts on the hypothalamus to control food 
intake, thermogenesis and insulin action by regulating expression and secretion of multiple 
neurotransmitters, neuropeptides and hypothalamic hormones including neuropeptide-Y 
(NPY) and different releasing hormones. In addition, leptin increases energy expenditure and 
the sympathetic tone as well as it modulates pituitary luteinizing hormone (LH), follicle 
stimulating hormone (FSH), growth hormone (GH), adrenocorticotropic hormone (ACTH) and 
thyroid stimulating hormone (TSH; modified from mediagnost). 
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In early postnatal life as well as prenatal life, leptin has essential functions as an 
endocrine modulator. One role proposed for leptin in utero is the partitioning of 
nutrients during the development of the feto-placental unit (Thomas et al., 2001). 
Furthermore, in animals such as the pig, in which fat is deposited before birth, leptin 
is synthesized in fetal adipose tissue and is present in the fetal circulation throughout 
late gestation (McMillen et al., 2004). Before birth, in the prenatal environment, leptin 
also may act as a signal of energy supply and has a ‘lipostatic’ role (McMillen et al., 
2004). As leptin has been implicated as a major sensor of energy and nutrient 
balance it is not surprising that the leptin axis is regulated by nutritional status 
(Houseknecht and Spurlock, 2003). In conjunction with nutritional status, leptin has 
also been implicated in nutritional programming during fetal and neonatal growth with 
perhaps long-term effects on the susceptibility to obesity and other long time 
consequences as for example diabetes (Eckert et al., 2000; Houseknecht and 
Spurlock, 2003). Different investigators kept track on the fact that in most obese 
mammals circulating leptin concentrations are high, indicating that the organism is 
resistant to the effects of leptin to inhibit feeding and increase metabolic rate. Based 
on these observations, the notion of ‘leptin resistance’ emerged (Houseknecht and 
Spurlock, 2003). The mechanisms of leptin resistance are only incompletely 
elucidated (Bjorbaek and Kahn, 2004). One hypothesis suggests that leptin 
resistance may in fact be programmed during fetal and neonatal life and may result in 
altered development of neuronal circuitry involved in food intake regulation (Djiane 
and Attig, 2008). 
In addition to its effects on energy homeostasis, leptin regulates neuroendocrine 
function and traditional endocrine systems (Kershaw and Flier, 2004) including the 
regulation of immune function, hematopoiesis, angiogenesis, and bone development. 
Leptin normalizes the suppressed immune functions associated with malnutrition and 
leptin deficiency (Lord et al., 1998). Leptin also promotes proliferation and 
differentiation of hematopoietic cells, it alters cytokine production by immune cells, 
stimulates endothelial cell growth and angiogenesis, and accelerates wound healing 
(Margetic et al., 2002). 
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2 Objectives 
The present study was undertaken to evaluate the effects of maternal protein deficit 
and excess throughout gestation on the development of the offspring at different 
ontogenetic stages. The investigation was focused on potential effects of the different 
maternal diets on the endocrine system, in particular the IGF-system that is known to 
play an important role in linking nutrition and growth. Deviant deflections of this 
system might have long term consequences for the offspring e.g. impaired growth 
and body composition. In this context, blood and liver samples of fetuses (dpc 94), 
newborn piglets (dpn 1), weaning piglets (dpn 28) and pigs at market weight 
(dpn 188) were used to assess several functional components of the IGF-system and 
to relate these with body growth data. Specifically the following tasks were defined: 
• The ligands, i.e. IGF-1 and -2 were quantified in blood plasma samples 
using commercially available Enzyme-linked Immunosorbent Assays 
(ELISA) for the human proteins after securing their applicability for porcine 
samples.  
• As the main target receptor, IGF-1 receptor was measured in liver tissue 
with a commercially available ELISA for human IGF-1 receptor that was 
also precedingly tested for its applicability in porcine liver samples.  
• In view of the important role of the IGF binding proteins within the IGF-
system, a semi quantitative nonradioactive Western ligand blot was 
established and validated to assess their abundance in the plasma 
samples.  
• For leptin, an adipose derived hormone with known interrelation to the IGF-
system, the concentrations were determined by an in-house developed 
ELISA after extensive validation for porcine plasma.  
• Identification of factors affecting the respective component of the IGF-
system, as well as characterization of relationships between the different 
target endocrine components. 
• Evaluation of potential long-term consequences of maternal diet, endocrine 
deflections and body growth patterns.  
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3 Material and Methods 
3.1 Animals and treatments  
All animal experiments were performed at the Leibniz Institute for Farm Animal 
Biology (FBN) in Dummerstorf. They were in strict accordance with the German 
animal protection law and were approved by the relevant authorities (Landesamt für 
Landwirtschaft, Lebensmittelsicherheit und Fischerei, Mecklenburg-Vorpommern, 
Germany). The samples collected as described below were made available within the 
scope of the joint project “FeproExpress” (coordinator: Dr. C. Metges, Research Unit 
Nutritional Physiology, FBN) funded by the German Federal Ministry of Education 
and Research (BMBF) through the program “FUGATO” (Functional Genome Analysis 
in Animal Organisms). 
Primiparous German Landrace gilts (n=78) were randomly allocated to 3 different 
feeding groups, receiving isoenergetic diets (~15.4 MJ ME/kg DM ) with either low 
(LP, 6 %; n=24), adequate (AP, 12 %; n=26), or high (HP, 30 %; n=28) crude protein 
contents corresponding to a protein:carbohydrate ratio of 1:10.4, 1:4.8 and 1:1.3, 
respectively, from mating until farrowing as described by Rehfeldt et al. (2011a). The 
offspring of these gilts was sampled as shown in Figure 4.  
 
 
Figure 4: Diagram showing the experimental design and the sampling days. 
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For the samplings on day 94 of gestation, 26 sows from the 3 different feeding 
groups (n = 7 to 8 each) were subjected to caesarian section and the fetuses were 
weighed and euthanized for collecting tissue and blood samples (n=68; AP=22, 
LP=22, HP=24). For sampling at later postnatal stages, the litter sizes and piglet birth 
weights were recorded from the remaining 52 gilts and the piglets were then cross 
fostered within 48 h after birth to nursing sows (2nd to 4th parity). These nursing sows 
were initially fed a standard gestation diet (11.4 MJ ME/kg, 12.6% crude protein) and 
then a standard lactation diet (~ 13.0 MJ ME/kg, 15.5% crude protein). Male piglets 
were castrated at 4 days of age. After weaning at day 28 of age, all piglets received 
standard fattening diets until slaughter (dpn 188) according to the recommendations 
of the Society for Nutrition Physiology (GfE, 2006). Tissue and blood samples were 
collected from the piglets on day 1 post natum (dpn 1; i.e. within 36 h after birth; 4 
piglets/litter n = 87; AP: n = 28, LP: n = 27, HP: n = 32), on dpn 28 prior to weaning (2 
piglets per litter, n = 78; AP: n = 23, LP: n = 25, HP: n = 30), and on dpn 188 prior to 
slaughter (2 piglets/litter; n = 73; AP: n = 26, LP: n = 23, HP: n = 24). For the sample 
collection on dpn 1 and 28, the piglets were euthanized as described earlier (Rehfeldt 
et al., 2011a); for dpn 188, the animals underwent the routine slaughter procedure.  
3.2 Sample collections and analyses 
All tissue samples were taken as soon as possible after death. For the present 
thesis, the focus was on blood and liver samples. Blood was collected from the 
euthanized fetuses and neonates from Vena cava cranialis. In later stages, dpn 28 
and 188, blood samples were withdrawn by venipuncture of jugular vein. Liver 
samples were immediately snap frozen in liqid nitrogen and then stored at -80°C until 
analysis. Body composition data were assessed and kindly made available from the 
cooperating partner institute, i.e. by Dr. C. Rehfeld. Research Unit Muscle Biology 
and Growth, FBN Dummerstorf. 
In blood serum, the concentrations of leptin, IGF-1 and IGF-2 were measured by 
enzyme-linked immune sorbent assays (ELISA). For assessing the IGF binding 
proteins (IGFBPs), a non-radioactive Western ligand blotting protocol was developed 
and applied for quantitative comparisons. In liver, IGF-1 receptor was assessed via 
ELISA. All assay procedures are described below. 
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3.2.1 ELISA for IGF-1  
IGF-1 in plasma was measured by a commercially available Sandwich-ELISA (IGF-1 
E-20, Mediagnost®, Reutlingen, Germany). In order to dissociate IGF-1 from the 
IGFBPs, the samples were diluted in acidic buffer. After neutralization of the samples 
in the wells, an excess of IGF-2 was used to occupy the IGF-binding sites of the 
binding proteins. Thereby potential interferences of IGFBPs in the assay can be 
circumvented, thus allowing for assessment of free IGF-1. Due to the negligible 
cross-reactivity of the IGF-1 antibody with IGF-2, excess IGF-2 does not disturb the 
interaction of the first antibody with IGF-1. The commercial assay was developed for 
use in human samples, however, due to the complete homology of the porcine and 
the human IGF-1 protein (Bayne et al., 1990), the assay can be used for porcine 
plasma. In confirmation of this, parallelism of serial dilutions of porcine plasma with 
the standard curve was demonstrated. The limit of detection was 0.09 ng/mL and the 
intra- and inter-assay coefficients of variation were 6.8% and 6.7%, respectively. 
3.2.2 ELISA for IGF-2 
Plasma IGF-2 was measured by a commercial sandwich-ELISA (IGF-2 E30, 
Mediagnost®, Reutlingen, Germany). The assay was also developed for use in 
human samples, however, due to the complete homology of the porcine and the 
human IGF-2 protein (Bayne et al., 1990), the assay can be used for porcine plasma. 
Similarly as for the IGF-1 assay, the samples were diluted in acidic buffer and the 
thereby released IGFBPs were blocked by an excess of IGF-1. Due to the negligible 
cross-reactivity of the IGF-2 antibody with IGF-1, excess IGF-1 does not interfere in 
the immune reaction. Free IGF-2 was detected with an analytical sensitivity of 0.02 
ng/mL and the intra- and inter-assay coefficients of variations were 6.6% and 7.2%, 
respectively. As for the IGF-1 assay, linearity of serial dilutions of porcine plasma 
samples was demonstrated thus confirming the applicability of the assay designed 
for human samples for porcine ones.  
3.2.3 Western ligand blots for the IGF-binding proteins  
The development of the technique of Western ligand blotting by Hossenlopp et al. 
(1986) provided a means for separating the various IGFBPs and determining their 
concentrations semiquantitatively. The IGFBPs in the biologic fluid of interest are 
separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
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PAGE) and are then transferred to sheets of nitrocellulose. The nitrocellulose sheets 
are incubated with 125I labeled IGF-1, which serves as a probe for the immobilized 
IGFBPs. The density of the bands can then be readily determined with use of a 
densitometer. The sensitivity of this method is sufficient but it employs radioactivity 
and several days of film exposure are required before results can be obtained. For 
the quantitative measurement of single IGFBPs, several immunological assays are 
available, but their use is mostly limited to human and rodent samples for which 
specific antibodies are available. For livestock species, adequate antibodies are only 
scarcely available (e.g. for bovine IGFBP-3: Hennies and Sauerwein, 2003). For pigs, 
antibodies are available for not any of the 6 high affinity IGFBPs. Therefore the 
Western ligand blot provides indeed a valuable alternative tool to detect the single 
BPs from any species by using the ligand (IGF-1 or IGF-2) instead of specific 
antibodies, provided the ligand is available. To overcome the disadvantages of using 
radioactivity for labeling the ligand, I herein developed a nonradioactive Western 
ligand protocol using biotinylated IGF-1 as first proposed by (Grulich-Henn et al., 
1998). Biotin is detected via its extraordinarily high affinity (Kd = 10
-15 M) to 
streptavidin (Bayer and Wilchek, 2006) using horseradish labeled streptavidin to 
generate a chemiluminescence signal which can then be densitometrically evaluated.  
3.2.3.1 Biotinylation of IGF-1  
Two hundred micrograms of IGF-1 (Novozymes GroPep, Adelaide, Australia) were 
dissolved in 200 µL 10 mM HCL and 800 µL 0.1 M NaHCO3 pH 9.0 were then 
incubated with 65 µL of a biotin (Sigma-Adrich Chemie GmbH, Munich, Germany) 
stock solution (10 mg/mL dimethylsulfoxide) for 4 h in the dark at room temperature, 
to give a final molar concentration of biotin:IGF-1 of 50:1. This ratio was based on 
preliminary studies showing that biotin:IGF-1 ratios of 50:1 or greater gave similar 
results when used for Western ligand blotting (data not shown). The cross linking 
reaction was terminated by adding 100 µL 1 M ammonium chloride (NH4Cl) and by 
separating the free and bound biotin on a PD-10 column (GE Healthcare, Munich, 
Germany, formerly Amersham Bioscience, Freiburg, Germany). The column was first 
allowed to reach room temperature and was then equilibrated with 3 column volumes 
of phosphate buffered saline (PBS) pH 7.5. The reaction mix was applied and 
subsequently eluted with PBS and collected in 0.5 mL fractions. One well-separated 
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peak containing the IGF-biotin esters was identified by UV absorbance at 280 nm. 
The peak eluate fractions (totally 6 with each 0.5 mL) were pooled and the total 
protein amount of 64 µg/mL was determined. Bovine serum albumin (BSA; Sigma-
Adrich Chemie GmbH, Munich, Germany) and glycerol (Applichem, Darmstadt, 
Germany) to a final concentration of 1% and 55%, respectively, were added. This 
solution was stored at -20°C and further used as ligand stock solution. 
3.2.3.2 Polyacrylamide gel electrophoresis (PAGE)  
Plasma samples as well as the reference standard (a pool of piglet plasma samples) 
were diluted 1:10 in water and mixed 1:5 with a non reducing 5x electrophoresis 
buffer (bromophenol blue, glycerol, β-mercaptoethanol, 20 % sodium dodecyl sulfate, 
1 M Tris-Hydrochloride, pH 6.8) and heated to 60°C for 20 min. The samples, the 
reference standard and a biotin labelled molecular weight marker (RPN 2107, GE 
Healthcare formerly Amersham Bioscience) were loaded onto a 5.6 % stacking gel 
and electrophoresed through a 12 % polyacrylamide gel. Except for the biotinylated 
molecular weight marker, the samples were run under non-reducing conditions. SDS-
PAGE was performed using a StarPhoresis 2-Gel Mini Vertical System (STARLAB, 
Ahrensburg, Germany), according to the method of Laemmli (Laemmli, 1970). In 
each case, two gels were run simultaneously at 150 mA until the dye front had 
proceeded nearly to the end of the gel.  
3.2.3.3 Western blotting  
Size-separated proteins were electrotransferred from the gel to HybondTM-P 
Membrane (GE Healthcare, Munich, Germany) according to the method of Kyhse-
Anderson (1984). After electrophoresis, the gels were fixed in anode-buffer-II 
containing 25 mM Tris and 10 % Methanol, pH 10.4 for 5 min. The polyvinylidine 
fluoride (PVDF) membranes were wetted in methanol for 15 sec and then 
equilibrated in anode-buffer-II for 5 min as well. The transfer of the proteins was 
completed within 45 min at a constant current of 50 V/membrane using a semi-dry 
Electro-Blotter (STARLAB). The non-specific binding sites on the membranes were 
then blocked by immersion in TBS buffer (10 fold: 0.05 M Tris and 0.9 % NaCl pH 
7.4) containing 0.1 % Tween-20 (TBST buffer) and 10 % Roti®-Block (Carl Roth 
GmbH + Co. KG, Karlsruhe, Germany) at 4°C overnight. 
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3.2.3.4 Enhanced chemiluminescence  
Membranes were probed for 2 h with biotin-labelled IGF-1 (100 ng/mL) and washed 5 
times (5 x 5 min) in TBST. The PVDF membrane was incubated with streptavidin-
peroxidase (Southern Biotech, Eching, Germany) (1:700,000) for 15 min and washed 
again 5 times. Membranes were covered by a mixture of equal volumes of enhanced 
chemiluminescence (ECL) detection reagent 1 and 2 (RPN 2135, GE Healthcare) in 
a final volume of 20 µL/cm² and incubated for 5 min in the dark without agitation. 
Excess detection reagent was drained off and the membranes were sealed in plastic 
and placed under a CL-XPosureTM Film (Thermo Scientific, Munich, Germany) in a 
cassette. The film was exposed for 2 min and developed immediately thereafter. The 
exposure time was adapted according to the intensity of the bands: exposure time 
varied from 2 to 10 min. The molecular weight of the developed bands was assessed 
by comparing with the molecular weight marker.  
3.2.3.5 Evaluation of data 
The chemiluminescent signals yielded were densitometrically evaluated and the 
relative quantities of the bands (42 kDa and 39 kDa, 34 kDa, 30 kDa, 24 kDa,) 
obtained were used for the subsequent statistical comparisons. The optical densities 
of the bands were matched against the reference standard from which the mean 
value of IGFBP-2 (34 kDa) was set as 100 % value. The relative amount of each 
major band was assessed on the basis of its surface area and the mean densitiy was 
expressed in % relative to the reference standard.  
3.2.4 Sandwich ELISA for IGF-1 receptor in liver 
For the analysis of IGF-1 receptor in liver, the tissue samples (pieces of 50-100 mg) 
were transferred into homogenization tubes (Precellys Ceramic Kit 1.4 mm, PEQLAB 
Biotechnologie GmbH, Erlangen, Germany) containing 800 µL RIPA-buffer (10mM 
Tris-HCL pH 7.4, 100 mM NaCl, 1 % Triton X-100, 0.5% sodium deoxycholate, 1 mM 
EDTA, 1 mM EGTA, 1 mM sodium fluoride, 20 mM sodium pyrophosphate, 2 mM 
sodium orthovanadate, 0.1% SDS, 10% glycerine, protease inhibitor complete® (1 
tablet/10 mL; Roche Diagnistics GmbH, Mannheim, Germany). The livers were 
homogenized two times at 5000 rpm for 15 sec with a 10 sec break between the 
intervals in a tissue homogenizer (Precellys24, PEQLAB Biotechnologie GmbH). The 
samples were then centrifuged by 4500 g for 10 min at 4°C; supernatants were 
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transferred into a new tube and again centrifuged with 1500 g for 5 min at 4°C. The 
resulting supernatants were retained and aliquoted. The concentration of total protein 
in the liver homogenates was measured with the method of Bradford (Bradford, 
1976) and the samples were stored at -20°C.  
The IGF-receptor was quantified in these homogenates using the UPSTATE® 
colorimetric STAR (Signal Transduction Assay Reaction) ELISA kit (MILLIPORE 
GmbH, Schwalbach, Germany). Before measurement, the liver homogenates were 
diluted with standard dilution buffer (MILLIPORE GmbH) to an end concentration of 
2.5 mg protein/mL and 100 µL of this dilution were used in the assay. To evaluate the 
applicability of this assay which is designed for human samples, for porcine liver, 
serial dilutions of porcine liver homogenates were tested and parallelism to the 
(human) IGF-1R standard curve could be confirmed. The inter-assay coefficient of 
variation was 12.9 % and the intra-assay coefficient of variation was 9.26 %. The limit 
of sensitivity was 0.13 ng IGF-1R. 
3.2.5 Competitive enzyme immunoassay for leptin  
Concentrations of plasma leptin were determined in duplicates in all blood samples 
by EIA as previously described (Sauerwein et al., 2004). Modifications of the assay 
included the use of a 30-fold molar excess relative to the leptin of 
biotinamidocaproate N-hydroxysuccinimide ester (Sigma Aldrich) for generating the 
biotinylated tracer, antiserum dilutions of 1:12,000 with assay buffer containing 1 % 
goose serum and the use of an incubation chamber at 25°C as well as the use of a 
horizontal shaker with 150-225 rotations/min for all incubations in microtiter plates. 
The limit of detection was 0.30 ng/mL and the intra- and inter-assay coefficients of 
variation were 6.3 % and 13.9 %, respectively. 
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3.3 Statistical analyses  
All statistical analyses were done using the SPSS 17.0 software for Windows (SPSS 
Inc., Chicago, IL, USA). The final plasma data (IGF-1, IGF-2, leptin, IGFBPs) was 
tested for Gaussian distribution by the Kolmogorov-Smirnov test and for homogeneity 
of variance by the Levene’s test. If data were normally distributed and variances 
homogeneous, parametric tests including the linear mixed model with piglets as 
repeated effects were executed using the following fixed factors: 
• maternal feeding group (LP, AP or HP), 
• piglet sex (female or (castrated) male),  
• fetal or birth body weight class  
o for dpn 94 fetuses: class 1 ≤ 0.65 kg; class 2 > 0.65 kg;  
o for birth weight: class 1 ≤ 1.3kg and class 2 >1.3kg 
• litter size group (class 1: < n = 12 and class 2: > 12 piglets/litter)  
• The respective interactions, i.e. maternal feeding group x piglet gender, 
maternal feeding group x litter size group, and maternal feeding group x fetal 
or birth body weight class.  
For group wise comparisons, the post hoc Bonferroni correction was applied. In case 
of not normally distributed data (and/or inhomogeneous variances), the 
nonparametric Kruskal-Wallis test was used. The results are displayed as means ± 
SE and the level of significance was set at P ≤ 0.05; a trend was defined at 
0.05 > P ≤ 0.1. 
Nonparametric Spearman rank correlation coefficients (correlations with P < 0.05 
were considered significant) were calculated. Correlation coefficients (r) between 0.4 
and 0.7 were classified as moderate and r > 0.7 as strong correlations. 
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4 Results 
The variables of the IGF-system investigated herein were mainly influenced by the 
maternal diet at dpc 94 and dpn 1. The later postnatal days of sampling (dpn 28 and 
188) only scarcely indicated effects of the differential protein supply of the dams. 
Leptin remained unchanged in response to the different feeding groups over all days. 
Effects of sex, litter size or body weights on the investigated variables were 
detectable at the different days of sampling with varying impact. The following 
detailed presentation of results is limited to significant differences observed for the 
fixed effects of maternal diet group, fetal or birth body weight class, litter size group, 
sex and the respective interactions. The particularities of all results are provided in 
the appendix. 
4.1 IGF-1 in plasma 
The mean concentrations of IGF-1 across all diet groups in plasma were between 
15.9 ng/mL on dpc 94 and 213.4 ng/mL on dpn 188. From dpc 94 to dpn 1 IGF-1 
increased to 34.0 ng/mL and to 116.4 ng/mL on dpn 28. As shown in Figure 5 and 
summarized in Table 1, fetuses of higher fetal body weight (> 0.65 kg) and piglets of 
higher birth weight (> 1.3 kg) had significantly greater IGF-1 concentrations on 
dpc 94 and dpn 1, when compared to the lower respective weight classes. At later 
postnatal days, IGF-1 concentrations were not different between the original birth 
weight classes. Sex affected IGF-1 values were solely observed on dpn 188 whereby 
male piglets had lower concentrations than females. With the exception of dpn 1, the 
IGF-1 concentrations remained unchanged in response to maternal dietary 
treatments. At this day, the piglets born to LP fed mothers showed a significantly 
decreased concentration of IGF-1 compared to HP piglets and tended (P = 0.083) to 
have a lower IGF-1 values than AP piglets. Piglets from smaller litters (< 12 piglets) 
had higher concentrations of IGF-1 on dpn 1 compared to piglets born to greater 
litters (> 12). In contrast, on dpn 28, piglets from litters > 12 had higher 
concentrations of IGF-1. 
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Figure 5: Developmental changes in the plasma concentrations of insulin like growth factor 1 
(IGF-1, means ± SE) in offspring of sows fed isoenergetic diets differing in protein content 
during gestation (⁄⁄⁄⁄ adequate protein, i.e. 12%, ■ high protein, i.e. 30% and □ low protein, i.e. 
6%); blood samples were collected from fetuses at day 94 of gestation (dpc 94) and from 
piglets on days 1, 28 and 188 post natum (dpn 1, 28, 188). Statistical results displayed as 
text insert in the figure comprise the effects of sex (females versus males; males were 
castrated during the first days of live), fetal body weight class (Fbwc1 ≤ 0.65 kg and Fbwc2 > 
0.65 kg), birth weight class (Bbwc1 ≤ 1.3 kg and Bbwc2 > 1.3 kg) and litter size group (Lsgr1 ≤ 
12 and Lsgr2 > 12 piglets/litter). Different lower case letters designate significant differences 
(P < 0.05) between diet groups within sampling day; different capital letters designate 
significant time-related differences between sampling days within the diet groups. N.S.: not 
significant. 
4.2 IGF-2 in plasma 
The average IGF-2 concentrations across all maternal diet groups rose from 25.9 
ng/mL on dpc 94 to 39.4 ng/mL on day 188. There was an increase in IGF-2 
concentrations from dpc 94 to dpn 1 (28.8 ng/mL) and also till dpn 28 (33.2 ng/mL). 
The IGF-2 concentrations in the offspring of the different maternal diet groups are 
shown in detail in Figure 6 and Table 1, respectively. At day 94 of gestation, the 
fetuses from the LP fed dams had lower IGF-2 plasma values than the offspring from 
AP and HP fed sows. Low body weight on dpc 94 (< 0.65 kg) and big litter size group 
(n > 12) on dpn 1 were associated with decreased IGF-2 concentrations. In addition, 
S N Sex: . .
Lsgr: P=0.012 (Lsgr1 > Lsgr2)
Bbwc:  N.S.
Diet x Lsgr: P=0.030
Sex: N.S.
Lsgr:  N.S.
Bbwc: N.S.
Sex: N.S.
Lsgr: N.S.
Fbwc: P=0.035 (Fbwc1 < Fbwc2)
Sex: N.S.
Lsgr: N.S.
Bbwc: N.S.
C C D
A B B
B             B            C
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an interaction (P=0.030) between maternal feeding group and litter size group was 
observed on dpn 1. At the later postnatal days 28 and 188, no significant differences 
between feeding group, sex, and litter size group or birth body weight class were 
ascertainable. 
Figure 6: Developmental changes in the plasma concentrations of insulin like growth factor 2 
(IGF-2, means ± SE) in offspring of sows fed isoenergetic diets differing in protein content 
during gestation (⁄⁄⁄⁄ adequate protein, i.e. 12%, ■ high protein, i.e. 30% and □ low protein, i.e. 
6%); blood samples were collected from fetuses at day 94 of gestation (dpc 94) and from 
piglets on days 1, 28 and 188 post natum (dpn 1, 28, 188). Statistical results displayed as 
text insert in the figure comprise the effects of sex (females versus males; males were 
castrated during the first days of live), fetal body weight class (Fbwc1 ≤ 0.65 kg and Fbwc2 > 
0.65 kg), birth weight class (Bbwc1 ≤ 1.3 kg and Bbwc2 > 1.3 kg) and litter size group (Lsgr1 ≤ 
12 and Lsgr2 > 12 piglets/litter). Different lower case letters designate significant differences 
(P < 0.05) between diet groups within sampling day; different capital letters designate 
significant time-related differences between sampling days within the diet groups. N.S.: not 
significant. 
calf piglet sow fetal pig cow
marker 1:5      1:10       1:5        1:10      1:5      1:10       1:5         1:10       1:5
97 kDa
66 kDa
45 kDa
31 kDa
20 kD a
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4.3 IGFBPs in plasma  
The Western blots of the IGF-binding proteins using biotin-labeled IGF-1 as ligand 
showed a distinct double band of 43 to 39 kDa (IGFBP-3), a band of 34 kDa 
(IGFBP-2), a ~ 30 kDa band (including IGFBP-1, but probably a mix of IGFBPs as for 
example IGFBP-5, degradation products of IGFBP-3 and/or glycosylated IGFBP-4) 
and a ~24 kDa band (IGFBP-4), as described for porcine serum (Hossenlopp et al., 
1986; Hardouin et al., 1989; McCusker et al., 1989; Yang et al., 1989; Lee et al., 
1991). IGFBP-3 was the most abundant binding protein, followed by IGFBP-2, 
IGFBP-4 and IGFBP-1 (representative example for a Western ligand blot is shown in 
Figure 7).  
 
 
Figure 7: A representative Western ligand blot of plasma pools of varying developmental 
stages and species in different dilutions pictured on a CL-XPosureTM Film exposed for 5 
minutes. 
 
IGFBP-1 could only be detected on dpc 94 and dpn 1 (Figure 8). On dpc 94, IGFBP-
1 was affected by maternal feeding: in HP fetuses, the IGFBP-1 concentrations were 
significantly higher than in AP fetuses and tended to be higher compared to 
respective LP group. The fetuses of the light fetal body weight class (< 0.65 kg) had 
higher IGFBP-1 values than the ones of the higher body weight class. At dpn 1, 
Sex: N.S.
Lsgr: N.S.
Fbwc: P=0.002 (Fbwc1 > Fbwc2)
Sex: N.S.
Lsgr: P=0.030 (Lsgr1 < Lsgr2)
Bbwc: N.S.
B            A            B
A A A                         
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piglets of the greater litter size group showed higher IGFBP-1 values than piglets of 
the smaller litter size group. Piglets from the sows fed a LP diet had 1.8 fold higher 
IGFBP-1 values on dpn 1 than on dpc 94. Piglets from AP sows showed a similar 
increase (1.5 fold) during this time interval, whereas the IGFBP-1 concentrations in 
offspring from HP fed sows remained unchanged.  
 
Figure 8: Developmental changes in the plasma concentrations of insulin like growth factor 
binding protein of 30 kDa (IGFBP-1, means ± SE) in offspring of sows fed isoenergetic diets 
differing in protein content during gestation (⁄⁄⁄⁄ adequate protein, i.e. 12%, ■ high protein, i.e. 
30% and □ low protein, i.e. 6%); blood samples were collected from fetuses at day 94 of 
gestation (dpc 94) and from piglets on days 1, 28 and 188 post natum (dpn 1, 28, 188). 
Statistical results displayed as text insert in the figure comprise the effects of sex (females 
versus males; males were castrated during the first days of live), fetal body weight class 
(Fbwc1 ≤ 0.65 kg and Fbwc2 > 0.65 kg), birth weight class (Bbwc1 ≤ 1.3 kg and Bbwc2 > 1.3 
kg) and litter size group (Lsgr1 ≤ 12 and Lsgr2 > 12 piglets/litter). Different lower case letters 
designate significant differences (P < 0.05) between diet groups within sampling day; 
different capital letters designate significant time-related differences between sampling days 
within the diet groups. N.S.: not significant, n.d.: not defined. 
 
The IGFBP-2 concentrations did not differ between sexes, litter size group or birth 
body weight classes on any day of sampling (Figure 9). However, IGFBP-2 was 
significantly influenced by maternal diet on dpn 1 and dpn 28. At both days, piglets 
born to LP fed mothers showed significantly decreased IGFBP-2 values compared 
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Lsgr: N.S.
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Diet x Bbwc: P=0.035
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B            B            A
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D           A            D
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with HP (dpn 1 and 28) and AP piglets (dpn 1). In addition, an interaction (P = 0.035) 
between maternal feeding group and body weight at birth was detected on dpn 28. In 
general, the highest IGFBP-2 values were recorded on dpn 1; age related differences 
were observed for all diet groups but slightly divergent patterns were observed. In LP 
and AP piglets, the nadir of IGFBP-2 concentrations was reached on dpn 28 and 
188, respectively. In HP piglets, the increase from dpc 94 to dpn 1 was apparent, too, 
but thereafter the values were returned to the level recorded on dpc 94. 
 
Figure 9: Developmental changes in the plasma concentrations of insulin like growth factor 
binding protein of 34 kDa (IGFBP-2, means ± SE) in offspring of sows fed isoenergetic diets 
differing in protein content during gestation (⁄⁄⁄⁄ adequate protein, i.e. 12%, ■ high protein, i.e. 
30% and □ low protein, i.e. 6%); blood samples were collected from fetuses at day 94 of 
gestation (dpc 94) and from piglets on days 1, 28 and 188 post natum (dpn 1, 28, 188). 
Statistical results displayed as text insert in the figure comprise the effects of sex (females 
versus males; males were castrated during the first days of live), fetal body weight class 
(Fbwc1 ≤ 0.65 kg and Fbwc2 > 0.65 kg), birth weight class (Bbwc1 ≤ 1.3 kg and Bbwc2 > 1.3 
kg) and litter size group (Lsgr1 ≤ 12 and Lsgr2 > 12 piglets/litter). Different lower case letters 
designate significant differences (P < 0.05) between diet groups within sampling day; 
different capital letters designate significant time-related differences between sampling days 
within the diet groups. N.S.: not significant. 
 
For the IGFBP-3 concentrations, an age related increase was observed in all diet 
groups (Figure 10) whereby the biggest difference between subsequent sampling 
Sex: N.S.
Lsgr: N.S.
Fbwc: N.S.
Sex: N.S.
Lsgr: P=0.000 (Lsgr1 > Lsgr2)
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Bbwc: N.S.
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days was from dpn 28 to 188. Comparing dpc 94 and dpn 188, 16-fold higher IGFBP-
3 values were seen on dpn 188. Differences related to maternal feeding group were 
limited to dpn 1 on which the concentration of IGFBP-3 in HP piglets was significantly 
higher than in AP piglets. For neither sex and body weight nor litter size group 
differences were detectable; the only exception was dpn 1 on which piglets from 
litters with less than 12 neonates had higher IGFBP-3 values than those from bigger 
litters.  
Figure 10: Developmental changes in the plasma concentrations of insulin like growth factor 
binding protein of 43-39 kDa (IGFBP-3, means ± SE) in offspring of sows fed isoenergetic 
diets differing in protein content during gestation (⁄⁄⁄⁄ adequate protein, i.e. 12%, ■ high 
protein, i.e. 30% and □ low protein, i.e. 6%); blood samples were collected from fetuses at 
day 94 of gestation (dpc 94) and from piglets on days 1, 28 and 188 post natum (dpn 1, 28, 
188). Statistical results displayed as text insert in the figure comprise the effects of sex 
(females versus males; males were castrated during the first days of live), fetal body weight 
class (Fbwc1 ≤ 0.65 kg and Fbwc2 > 0.65 kg), birth weight class (Bbwc1 ≤ 1.3 kg and Bbwc2 > 
1.3 kg) and litter size group (Lsgr1 ≤ 12 and Lsgr2 > 12 piglets/litter). Different lower case 
letters designate significant differences (P < 0.05) between diet groups within sampling day; 
different capital letters designate significant time-related differences between sampling days 
within the diet groups. N.S.: not significant. 
 
Detection of IGFBP-4 was limited for dpc 94, dpn 1 and dpn 28 (Figure 11). On 
dpn 1, the IGFBP-4 concentrations were in average 3.2 and 4.7-fold higher than on 
Sex: N.S.
Lsgr: N.S.
Fbwc: N.S.
Sex: N.S.
Lsgr: P=0.038 (Lsgr1 > Lsgr2)
Bbwc: N.S.
Sex: N.S.
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Bbwc: N.S.
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A            A            A
A            C            A
n.d.
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dpc 94 and dpn 28, respectively. The values rose from 6 % on dpc 94 to 20 % on 
dpn 1 and then decreased at dpn 188 to initial values. On neither of the sampling 
days, differences between the diet groups occurred. For litter size group, there was 
an effect on dpn 1 whereby piglets from smaller litters showed higher IGFBP-4 
values than those from litters bigger than 12 piglets. Sex and body weight at delivery 
did not affect IGFBP-4. 
Figure 11: Developmental changes in the plasma concentrations of insulin like growth factor 
binding protein of 24 kDa (IGFBP-4, means ± SE) in offspring of sows fed isoenergetic diets 
differing in protein content during gestation (⁄⁄⁄⁄ adequate protein, i.e. 12%, ■ high protein, i.e. 
30% and □ low protein, i.e. 6%); blood samples were collected from fetuses at day 94 of 
gestation (dpc 94) and from piglets on days 1, 28 and 188 post natum (dpn 1, 28, 188). 
Statistical results displayed as text insert in the figure comprise the effects of sex (females 
versus males; males were castrated during the first days of live), fetal body weight class 
(Fbwc1 ≤ 0.65 kg and Fbwc2 > 0.65 kg), birth weight class (Bbwc1 ≤ 1.3 kg and Bbwc2 > 1.3 
kg) and litter size group (Lsgr1 ≤ 12 and Lsgr2 > 12 piglets/litter). Different lower case letters 
designate significant differences (P < 0.05) between diet groups within sampling day; 
different capital letters designate significant time-related differences between sampling days 
within the diet groups. N.S.: not significant; n.d.: not defined. 
4.4 IGF-1 receptor in liver tissue 
The concentrations of IGF-1 receptor in liver were below the limit of detection of the 
assay at any of the postnatal days. For the fetal stage assessed on dpc 94, the 
Results  37 
 
 
 
 
average concentration across all diet groups was 1.61 ng/mL (Table 1). Neither 
maternal feeding group, body weight, litter size nor sex apparently influenced IGF-1 
receptor content on dpc 94 in liver. 
4.5 Leptin in plasma 
On dpc 94, the concentrations of leptin were below the assay limit of detection 
(0.3 ng/mL). The concentrations assessed postnatal are shown in Figure 12 and 
Table 1, respectively. The average leptin plasma concentrations of 4.0 ng/mL on 
dpn 1 correspond to a more than 10-fold increase compared to dpc 94. Comparing 
dpn 1 and 28, a significant decrease was observed in the HP and LP piglets, and - 
albeit not reaching the level of significance – in AP piglets. The highest leptin plasma 
concentrations (average 4.6 ng/mL) were consistently reached in all diet groups by 
dpn 188 and were about 1 ng/mL higher than on dpn 1. The leptin concentrations 
were neither affected by sex nor by litter size group. However, on dpn 1 there was an 
interaction between maternal feeding group and litter size group (P = 0.014). Birth 
weight classes were not different with the exception of dpn 28 where piglets with 
higher birth body weight exhibited significantly higher leptin concentrations than 
piglets of lower body weight at birth.  
Sex: N.S.
Lsgr: N.S.
Bbwc: N.S.
Diet x Lsgr: P=0.014
Sex: N.S.
Lsgr: N.S.
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Figure 12: Developmental changes in the plasma concentrations of Leptin (means ± SE) in 
offspring of sows fed isoenergetic diets differing in protein content during gestation 
(⁄⁄⁄⁄ adequate protein, i.e. 12%, ■ high protein, i.e. 30% and □ low protein, i.e. 6%); blood 
samples were collected from fetuses at day 94 of gestation (dpc 94) and from piglets on days 
1, 28 and 188 post natum (dpn 1, 28, 188). Statistical results displayed as text insert in the 
figure comprise the effects of sex (females versus males; males were castrated during the 
first days of live), fetal body weight class (Fbwc1 ≤ 0.65 kg and Fbwc2 > 0.65 kg), birth weight 
class (Bbwc1 ≤ 1.3 kg and Bbwc2 > 1.3 kg) and litter size group (Lsgr1 ≤ 12 and Lsgr2 > 12 
piglets/litter). Different lower case letters designate significant differences (P < 0.05) between 
diet groups within sampling day; different capital letters designate significant time-related 
differences between sampling days within the diet groups. N.S.: not significant; n.d.: not 
defined. 
Sex: N.S.
Lsgr: P=0.002 (Lsgr1 > Lsgr2)
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4.6 Body composition at the postnatal days 
Slaughter weight (SW) and hot carcass weight (HCW) as well as percentages of 
carcass protein, lipid and dry matter were recorded at dpn 1, 28 and 188 (Table 2). 
At their first day of life, piglets exposed to maternal LP diet in utero had lower body 
weights (P = 0.029) and hot carcass weights (P = 0.025) compared to the AP piglets. 
For both variables, piglets of greater litters showed lower weights and as a matter of 
course, piglets of the lighter birth weight class showed lower slaughter and hot 
carcass weights, too (Figure 13 and Figure 14). 
 
Figure 13: Slaughter weights (means ± SE) of offspring of sows fed isoenergetic diets 
differing in protein content during gestation (⁄⁄⁄⁄ adequate protein, i.e. 12%, ■ high protein, i.e. 
30% and □ low protein, i.e. 6%); slaughter weights were determined from piglets on days 1, 
28 and 188 post natum (dpn 1, 28, 188). Statistical results displayed as text insert in the 
figure comprise the effects of sex (females versus males; males were castrated during the 
first days of live), birth weight class (Bbwc1 ≤ 1.3 kg and Bbwc2 > 1.3 kg) and litter size group 
(Lsgr1 ≤ 12 and Lsgr2 > 12 piglets/litter). Different lower case letters designate significant 
differences (P < 0.05) between diet groups within sampling day; different capital letters 
designate significant time-related differences between sampling days within the diet groups. 
N.S.: not significant. 
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 Results 
Sex: N.S.
Lsgr: P=0.003 (Lsgr1 > Lsgr2)
Bbwc: P=0.000 (Bbwc1 < Bbwc2)
Sex: N.S.
Lsgr: N.S.
Bbwc: P=0.000 (Bbwc1 < Bbwc2)
Sex: N.S.
Lsgr: N.S.
Bbwc: : P=0.028 (Bbwc1 < Bbwc2)
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Figure 14: Hot carcass weights (means ± SE) of offspring of sows fed isoenergetic diets 
differing in protein content during gestation (⁄⁄⁄⁄ adequate protein, i.e. 12%, ■ high protein, i.e. 
30% and □ low protein, i.e. 6%); hot carcass weights were determined from piglets on days 
1, 28 and 188 post natum (dpn 1, 28, 188). Statistical results displayed as text insert in the 
figure comprise the effects of sex (females versus males; males were castrated during the 
first days of live), birth weight class (Bbwc1 ≤ 1.3 kg and Bbwc2 > 1.3 kg) and litter size group 
(Lsgr1 ≤ 12 and Lsgr2 > 12 piglets/litter). Different lower case letters designate significant 
differences (P < 0.05) between diet groups within sampling day; different capital letters 
designate significant time-related differences between sampling days within the diet groups. 
N.S.: not significant. 
 
In addition, piglets of higher birth weights had higher percentages of fat at dpn 1 (P = 
0.020). For the percentages of protein and dry matter, an interaction between diet 
and litter size group was detectable (P = 0.003 and P = 0.009, respectively). For all 
postnatal days significant differences of SW and HCW between the birth weight 
classes were observed (dpn 1 = SW: P < 0.001, HCW: P < 0.001; dpn 28 = SW: P < 
0.001, HCW: P < 0.001; dpn 188= SW: P = 0.038, HCW: P = 0.028). As a matter of 
course, piglets with birth weights > 1.3 kg had significantly higher SW and HCW 
compared to piglets with lower birth weights (< 1.3 kg). On dpn 28, fat and dry matter 
content were affected (P < 0.05) by maternal feeding, litter size and birth weight 
(Figure 15 and Figure 16). Fat and dry matter content were higher in piglets born to 
LP fed mothers than in HP and AP piglets. Besides, piglets of low birth weight and 
Sex: N.S.
Lsgr: N.S.
Bbwc: P=0.020 (Bbwc1 < Bbwc2)
Sex: N.S.
Lsgr: P=0.024 (Lsgr1 < Lsgr2)
Bbwc: P=0.028 (Bbwc1 < Bbwc2)
Diet x Lsgr: P=0.045
Sex: P=0.000 (Male > Female) 
Lsgr: N.S.
Bbwc: N.S.
Diet x Lsgr: P=0.043
C                 C                 C
B                  B                 B
a ab b                                 
A                 A                 A
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piglets out of small litters exhibited lower percentages of carcass fat and dry matter 
compared to piglets of heavier birth weights and offspring out of large litters. For both 
variables, there was an interaction between diet (P = 0.045) and litter size group 
(P = 0.044). 
 
Figure 15: Percentages of fat (means ± SE) in offspring of sows fed isoenergetic diets 
differing in protein content during gestation (⁄⁄⁄⁄ adequate protein, i.e. 12%, ■ high protein, i.e. 
30% and □ low protein, i.e. 6%); percentages of fat were determined from piglets on days 1, 
28 and 188 post natum (dpn 1, 28, 188). Statistical results displayed as text insert in the 
figure comprise the effects of sex (females versus males; males were castrated during the 
first days of live), birth weight class (Bbwc1 ≤ 1.3 kg and Bbwc2 > 1.3 kg) and litter size group 
(Lsgr1 ≤ 12 and Lsgr2 > 12 piglets/litter). Different lower case letters designate significant 
differences (P < 0.05) between diet groups within sampling day; different capital letters 
designate significant time-related differences between sampling days within the diet groups. 
N.S.: not significant. 
Sex: N.S.
Lsgr: N.S.
Bbwc: N.S.
Diet x Lsgr: P=0.009
Sex: N.S.
Lsgr: P=0.039 (Lsgr1 < Lsgr2)
Bbwc: P=0.023 (Bbwc1 < Bbwc2)
Diet x Lsgr: p=0.044
Sex: P=0.000 (Male > Female)
Lsgr: N.S.
Bbwc: N.S.
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A                 A                 A
a                ab                b
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Figure 16: Content of dry matter (means ± SE) in offspring of sows fed isoenergetic diets 
differing in protein content during gestation (⁄⁄⁄⁄ adequate protein, i.e. 12%, ■ high protein, i.e. 
30% and □ low protein, i.e. 6%); the dry matter content were determined from piglets on days 
1, 28 and 188 post natum (dpn 1, 28, 188). Statistical results displayed as text insert in the 
figure comprise the effects of sex (females versus males; males were castrated during the 
first days of live), birth weight class (Bbwc1 ≤ 1.3 kg and Bbwc2 > 1.3 kg) and litter size group 
(Lsgr1 ≤ 12 and Lsgr2 > 12 piglets/litter). Different lower case letters designate significant 
differences (P < 0.05) between diet groups within sampling day; different capital letters 
designate significant time-related differences between sampling days within the diet groups. 
N.S.: not significant. 
 
At dpn 188, the percentages of protein, fat and dry matter where affected by sex in 
that castrated males had lower carcass protein contents (P < 0.001) compared to 
females, but higher fat (P < 0.001) and dry matter percentages (P < 0.001, Figure 17, 
Figure 15 and Figure 16). An interaction between diet and litter size group was 
observed for carcass protein and fat content (P = 0.018 and P = 0.043, respectively). 
Expectedly, SW, HCW, lipid and dry matter percentages increased from dpn 1 to 
dpn 188 significantly. 
Sex: N.S.
Lsgr: N.S.
Bbwc: N.S.
Diet x Lsgr: P=0.003
Sex: N.S.
Lsgr: N.S.
Bbwc: N.S.
Sex: P=0.000 (Male < Female)
Lsgr: N.S.
Bbwc: N.S.
Diet x Lsgr: P=0.018
B                  B                 B
C                 C                 C
A                 A                A
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Figure 17: Percentages of protein (means ± SE) in offspring of sows fed isoenergetic diets 
differing in protein content during gestation (⁄⁄⁄⁄ adequate protein, i.e. 12%, ■ high protein, i.e. 
30% and □ low protein, i.e. 6%); the percentages of protein were determined from piglets on 
days 1, 28 and 188 post natum (dpn 1, 28, 188). Statistical results displayed as text insert in 
the figure comprise the effects of sex (females versus males; males were castrated during 
the first days of live), birth weight class (Bbwc1 ≤ 1.3 kg and Bbwc2 > 1.3 kg) and litter size 
group (Lsgr1 ≤ 12 and Lsgr2 > 12 piglets/litter). Different lower case letters designate 
significant differences (P < 0.05) between diet groups within sampling day; different capital 
letters designate significant time-related differences between sampling days within the diet 
groups. N.S.: not significant. 
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4.7 Correlations 
4.7.1 Correlations on each sampling day within the three different maternal   
 feeding groups 
Correlations between the various variables assessed (plasma concentrations of IGF-
1, IGF-2, IGFBPs 1-4, and leptin, liver IGF-1R content, body weight at birth, slaughter 
weight, hot carcass weight as well as dry matter, protein and fat portion of the 
carcass) were calculated for dpn 1, 28 and 188 within the 3 different maternal feeding 
groups AP, HP and LP and are depicted in Figure 18.  
Figure 18: Spearman correlation coefficients between the components of the IGF-system 
and leptin measured in plasma and of various carcass characteristics assessed on day 1, 28 
an 188 of postnatal life (dpn) in offspring from sows fed isoenergetic diets with low (LP), 
adequate (AP), and high (HP) protein contents. Positive significant correlations are in red, 
negative significant correlations are displayed in blue (P ≤ 0.05). The presentation is limited 
to correlations with r ≥ 0.4; moderate correlations (0.4 < r ≤ 0.70) are indicated by dashed 
lines and strong correlations (r > 0.7) by unbroken lines. Variables: birth weight (BW), 
slaughter weight (SW), hot carcass weight (HCW), carcass dry matter content (DM), carcass 
fat content (FAT), carcass protein content (Prot); Concentrations: insulin-like growth factor 1 
(IGF-1), insulin-like growth factor 2 (IGF-2), insulin-like growth factor binding proteins 1-4 
(BP-1, BP2, BP 3, and BP 4), leptin (Lep). 
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The display is limited to significant correlations with r ≥ 0.4. Negative and positive 
correlations of moderate (r = 0.4 – 0.7) as well as of strong intensities (r > 0.7) were 
identified. Apparently dpn 28 had the most correlations in all three diets in 
comparison to dpn 1 and dpn 188, whereas dpn 188 showed only a few correlations 
between the variables assessed. For the variables of carcass composition, 
correlation of dpn 188 were mostly observed between these variables whereas, 
correlations between carcass composition data and the IGF-system disappeared as 
compared to earlier ages. In both the LP and the HP group, the correlation between 
fat and dry matter content was negative, but was positive in the AP group. 
4.7.2 Correlations within dpc 94, dpn 1, dpn 28 and dpn 188 irrespective of  
 feeding group  
Taking all data from the different feeding groups together for a pooled assessment of 
correlations within the different days provided the results presented in Table 3. The 
significant correlations detected and displayed in this table ranged between r = 0.18 
and r = 0.889. Positive correlations of IGF-1 were found with IGF-2 on dpc 94, and 
dpn 28 (Table 3).  
Negative associations between IGF-1 and the IGFBPs were apparent for IGFBP-1 on 
dpc 94 and dpn 1, and for IGFBP-2 on dpn 28. The only positive association of IGF-1 
with the IGFBPs was limited to IGFBP3 on dpn 28. The correlations of IGF-2 with the 
IGFBPs showed a similar pattern, i.e. positive correlations were limited to IGFBP-3 
on dpc 94 and dpn 28, and negative correlations were evident for IGFBP-2 (dpn 28) 
and IGFBP-1 (dpc 94, dpn 1). Interrelationships between the different IGFBPs were 
mostly limited to the fetal stage and were consistently positive, i.e. on dpc 94; IGFBP-
3 was correlated with IGFBP-2, -1 and -4. Further associations between the other 
IGFBPs were also exclusively positive and occurred between IGFBP-2 and -1 on 
dpc 94 and dpn 1 and between IGFBP-2 and -4 on dpn 28. IGFBP-1 was also 
correlated with IGFBP-4 on dpc 94.  
Postnatal associations between the components of the IGF-system and leptin were 
exclusively positive for IGF-1 and IGF-2. Correlations between leptin and the IGFBPs 
were either positive (IGFBP-3 on dpc 94 and IGFBP-4 on dpn 1) or negative in case 
of IGFBP-1 (dpn 1). 
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Considering potential relationships between the IGF-system and carcass 
characteristics, exclusively positive correlations were observed for IGF-1, IGF-2 and 
IGFBP-3, whereas occasional correlations between the other IGFBPs with carcass 
traits were consistently negative. Leptin was positively correlated to most carcass 
traits but the correlation was relatively weak: the r values ranged between 0.243 
(leptin x protein portion on dpn 28) and 0.423 (leptin x fat portion on dpn 1). 
Interestingly for dpn 188 there were only a few and weak correlations detectable: 
IGF-1 and IGFBP-3 as well as IGFBP-3 and IGFBP-2 were positively correlated 
(r =0.256 and r = 0.299, respectively. Between IGF-1 and IGFBP-2 were a negative 
correlation observed (r= -0.381). In favor of a better general view of Table 3, the few 
correlations of dpn 188 are not presented. 
4.7.3 Correlations over all days irrespective of feeding group  
IGF-1 was highly correlated in a positive or negative way to nearly all parameters 
tested (Table 3). Correlations between IGF-1 and IGFBP-1, -2 and -4 were negative. 
All other significant correlations of IGF-1 were positive. The same pattern was found 
for IGF-2, but the correlation was weaker as indicated by generally lower r values 
(Table 3). Correlations of IGFBP-1 and IGFBP-4 with slaughter weight, hot carcass 
weight as well as percentages of fat and dry matter over all days of sampling were 
high and consistently negative (r values between -0.816 and -0.868). IGFBP-1 and -4 
were also negatively correlated with carcass fat content but these correlations were 
only moderate (r = -0.671 and -0.492, respectively). A highly positive correlation was 
found between IGFBP-1 and IGFBP-4. For leptin weak positive correlations with all 
carcass traits were confirmed with the exception of carcass protein content for which 
r = -0.18 was observed. 
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5 Discussion 
5.1 Leptin 
In the current study, the observation of slightly decreasing leptin concentrations from 
early postnatal life until day 28 post natum and a further increase to later ages 
agrees with previous studies (Qian et al., 1999; Morise et al., 2009). Leptin secretion 
and consequently its plasma concentration are positively correlated with total fat 
mass (Hamilton et al., 1995; Houseknecht and Portocarrero, 1998; Wajchenberg, 
2000; Fain et al., 2004) which normally increases with age in growing individuals. 
The three different protein levels in the maternal diets tested in the present study had 
no effect on the concentrations of leptin in the offspring over all postnatal days. Due 
to the fact that all piglets after birth were cross fostered to sows fed an adequate 
protein diet during gestation and lactation, these findings suggest that potential 
prenatal differences in leptin plasma concentrations which may have resulted from 
intra uterine protein deficit or excess, are possibly compensated by the homogenous 
and adequate protein supply through milk from the foster sows in the early postnatal 
days.  
In samples obtained during fetal life, i.e. on dpc 94, leptin could not be assessed 
since the concentrations were mostly below the assay`s limit of detection at 0.3 
ng/mL. From previous studies reporting leptin blood concentrations of 0.1 to 
0.8 ng/mL in unsuckled neonatal piglets (Tatara et al., 2007; Szymeczko et al., 
2009), relatively low concentrations had to be expected and thus it was not surprising 
that the prenatal concentrations could not be quantified. However, in animals such as 
the pig, in which fat is deposited before birth, leptin is synthesized in fetal adipose 
tissue and is present in the fetal circulation throughout late gestation albeit at low 
concentrations (McMillen et al., 2004). 
The new born piglets had mean plasma leptin concentrations of 4.1 ng/mL. When 
comparing these values with the prenatal concentrations being below the limit of 
detection of the assay used and also when comparing with literature data (see Table 
4), we obtained considerably lower concentrations. The most probable explanation 
for this rapid increase is intestinal absorption of leptin from colostrum: The mammary 
gland is able to produce leptin, particularly during the early phase of lactation (Smith-
Kirwin et al., 1998; Smith and Sheffield, 2002) and leptin is secreted into milk and is 
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thus potentially available for the newborn (Uysal et al., 2002). In rats, leptin is 
transferred from the maternal circulation to the milk then to the stomach of the 
suckling pup, and afterwards to the neonatal circulation (Casabiell et al., 1997). The 
piglets in the present study were already suckled before blood samples could be 
collected on dpn 1 and thus the relatively high plasma concentrations of leptin 
probably resulted from the absorption of leptin contained in colostrum. In support of 
this notion, Szymeczko et al. (2009) showed a significant increase due to suckling in 
blood leptin concentrations from newborn piglets within 24 h; see also Table 4. 
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Table 4: Plasma concentrations of leptin, IGF-1 and IGF-2 in fetuses and piglets  
  of different developmental stages 
author, year dpc dpn leptin (ng/mL) IGF-1 (ng/mL) IGF-2 (ng/mL)
1 16.3
2 12.5
7 22.5
28 21.0
70 7.5 135
90 13.0 210
110 20.0 200
90 17.9 200
1 50.0 230
30 150.0 370
90 10.1 88
21 90.6 220
170 182.3 326
1 200.0-320.0 290
28 250.0 180
188 80.0 120
90 70.0 430
1 135.0 460
21 165.0 490
180 240.0 720
98-113 250.0
300-360 150.0-190.0
42 - 49 0.60
105 - 112 2.70
140 - 154 3.00
1 29.0 80
14 35.0 60
70 98.0-125.0
90 148.0
Weiler et al., 2002 19 1.24
Mostyn et al., 2005 4 2.90 34.3
7 2.90 46.5
14 2.90 44.1
Litten et al., 2005 3 - 10 2.50 - 2.90
Tatara et al., 2007 1* 0.10 60.2
1* 0.78
1 1.87
7 1.87
7 2.50 26.0
28 1.60 21.5
Morise et al., 2009
Peng et al., 1996
Bauer and Parvizi, 1996
Qian et al., 1999
Carroll et al., 2000
Clapper et al., 2000
Szymeczko et al., 2009
day of sampling
Simmen et al., 1988
Hausmann et al., 1991
Lee et al., 1991
Lee et al., 1993
Buonomo et al., 1993
 
Abbreviations: dpc: days post conception, dpn: days post natum, *: before suckling. 
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In our study, piglets of the higher birth weight class had significantly higher leptin 
concentration compared to piglets of the lower birth weight class on dpn 28. Different 
previous studies reported a positive correlation between leptin plasma concentration 
with total fat mass as mentioned before. Thus leptin circulates as an internal signal 
indicating the size of body fat stores (Reidy and Weber, 2000). Indeed, the body 
composition analyses showed that the piglets with higher birth weights had higher 
lipid contents in empty body (13.5 %) and higher slaughter weights (8.2 kg) on 
dpn 28 in comparison to the piglets of lower birth weights (12.8 % and 6.8 kg, 
respectively; Table 5). We also found a positive correlation between leptin and body 
fat content for the piglets on dpn 1 and dpn 28, and also a positive correlation 
between leptin and slaughter weight at these two postnatal days. In addition, leptin 
and slaughter weight were correlated over all postnatal days.  
 
Table 5: Amounts and concentrations of slaughter weight, leptin and fat (means ± SE) 
between piglets of the low and high birth body weight class at different age. 
mean SE mean SE
dpn 1 Slaughter weight (kg) 1.03 ± 0.03 1.67 ± 0.03
Leptin (ng/mL) 3.76 ± 0.24 3.93 ± 0.22
Fat (%) 1.56 ± 0.07 1.87 ± 0.09
dpn 28 Slaughter weight (kg) 6.76 ± 0.23 8.20 ± 0.25
Leptin (ng/mL) 2.92 ± 0.11 3.27 ± 0.09
Fat (%) 12.76 ± 0.38 13.50 ± 0.37
dpn 188 Slaughter weight (kg) 124.8 ± 1.52 131.80 ± 2.12
Leptin (ng/mL) 4.63 ± 0.25 4.87 ± 0.20
Fat (%) 30.2 ± 0.72 29.66 ± 0.69
<1.3 kg >1.3 kg
Birth body weight class
 
Abbreviations: SE: standard error, dpn: days post natum, dpc: days post conception. 
 
Interestingly, on dpn 188, the leptin concentrations of high versus low birth weight 
piglets were not different, although the difference between the two birth weight 
classes in slaughter weights was maintained at this age. Houseknecht and Spurlock 
(2003) perceived leptin as a major sensor of energy and nutrient balance and 
speculated about its regulation by the nutritional status. In this context, leptin has 
also been associated with nutritional programming during fetal and neonatal growth 
which may lead to long-lasting effects (Eckert et al., 2000; Houseknecht and 
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Spurlock, 2003). Our findings indicate that there was a short time effect of the 
different intrauterine environments on fat content and body weights of the offspring, 
but these effects were not maintained until later adolescent stages. Furthermore our 
results show that plasma leptin was not affected by nutritional status in terms of 
intrauterine protein deficit or excess. In our study, leptin was not as highly correlated 
to body composition traits, in particular fat percentage of the whole empty body, as 
might have been expected. Analogous findings are reported for the sows of the 
present study by Metges et al. (under revision) and Rehfeldt et al., (2011a): although 
the increase of back fat thickness in the HP diet group was least from insemination 
until 109 dpc; this difference in comparison to the AP and LP diet group was not 
reflected by concordant differences in leptin concentrations. However, when verifying 
correlations of plasma leptin with carcass characteristics, the associations reported in 
the literature for pigs (Berg et al., 2003), were mostly not as close as for humans or 
laboratory rodents (Frederich et al., 1995; Maffei et al., 1995). This might be due to 
the fact that most model studies in which close relations could be established 
included a relatively wide range of different body fat contents, i.e. from lean to 
morbidly obese individuals. In contrast, studies in livestock species usually consider 
less variation in relatively homogenous groups. Taken together, the suitability of 
leptin as strong indicator of body composition in pigs at marketing age is not 
supported.  
In prenatal as well as in early postnatal life, leptin has essential functions as an 
endocrine modulator just as the IGFs for the IGF-system at these stages of 
development. Leptin has a key role in energy homeostasis and there may be a link 
between leptin and the IGF-system. Experimental models have provided evidence of 
leptin functioning as a neuromodulator of the GH-IGF axis by connecting this 
hormonal system with nutritional status (LaPaglia et al., 1998). Interestingly, as the 
IGF-system is known to be deficient in the case of IUGR (Woodall et al., 1996), it can 
be speculated that the actions of leptin on body and organ growth are at least 
partially mediated by stimulation of the IGF-system. Anyway, changes in circulating 
IGF-1 concentrations are positively correlated with changes in leptin blood levels 
(Heiman et al., 1999), and indeed we also observed positive correlations between 
IGF-1 and leptin on dpn 1 and dpn 28 as well as over all postnatal days.  
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5.2 IGF-1 and -2 
In contrast to leptin, the IGF-1 concentrations were well detectable in fetal samples. 
The concentrations of IGF-1 at the different sampling days and their age-related 
changes were in compliance with previous studies in pigs (Hausman et al., 1991; Lee 
et al., 1991; Lee et al., 1993; Peng et al., 1996; Carroll et al., 2000; Mostyn et al., 
2006) as exemplified in Table 4. With the exception of dpn 1, the IGF-1 
concentrations remained unchanged in response to maternal dietary treatments. At 
dpn 1, the piglets born to mothers fed the LP diet with only 6% protein during 
gestation had significantly decreased IGF-1 concentrations compared to piglets born 
to mothers fed the HP diet (30 % protein) and tended to have lower IGF-1 values 
than piglets born to mothers fed an adequate protein diet during gestation. In a study 
by Davis et al. (1997), an analogous finding for decreasing IGF-1 concentrations in 
newborn pigs from dams fed protein restricted diets (0.5% protein) throughout 
gestation was obtained. In adult humans, and also in other species, serum IGF-1 
concentrations are markedly lowered by protein deprivation (Thissen et al., 1994; 
Breier and Sauerwein, 1995). Due to the fact that the availability of dietary protein is 
one main critical regulator of IGF-1, dietary protein supply seems to be the limiting 
factor for maximal stimulation of IGF-1 plasma concentrations (Breier, 1999).  
In parallel with the results of the IGF-1 concentrations in LP piglets on dpn 1, the 
present investigation also revealed significantly lower IGF-1 concentrations in piglets 
of lower birth weight, when compared to the higher birth weight class and thus 
confirmed earlier studies (Davis et al., 1997; Ritacco et al., 1997). As expected, the 
piglets born to mothers fed the low protein diet had lower slaughter weights than the 
AP and HP piglets. Consequently, we could demonstrate a positive correlation 
between the IGF-1 concentrations and the body weights of the piglets at dpn 1. 
These findings are consistent with recent investigations in which positive correlations 
between the IGF concentrations in the fetus and birth weight were established in 
several species including humans, sheep, rodents and pigs (Daughaday et al., 1982; 
Gluckman and Butler, 1983; Lee et al., 1993; Ong et al., 2000). Moreover, we 
showed that piglets from smaller litters had higher concentrations of IGF-1 on dpn 1 
as compared to piglets born to greater litters. This observation is in line with the fact 
that the piglets from smaller litters also had higher slaughter weights than piglets out 
of greater litters (Table 6).  
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In contrast, on dpn 28, piglets from greater litters had higher concentrations of IGF-1 
and exhibited higher slaughter weights than compared to piglets from smaller litters. 
For both days positive correlations between IGF-1 concentration and slaughter 
weight were obtained. The reversals of the observations of dpn 1 versus dpn 28 
suggest a trend towards a compensatory response to the maternal protein restriction. 
Compensatory growth is a well-known phenomenon (Lawrence and Fowler, 1997), 
for piglets, the work of Schoknecht et al. (1993) exemplarily shows, that once solid 
food was offered to weight reduced suckling piglets, these piglets gained weight and 
were the same weight compared to the other piglets after some weeks. At later 
postnatal days, the IGF-1 concentrations were not different between the original birth 
weight classes. These results are in line with the statement of Fliesen et al. (1989) 
whereupon the serum IGF-1 concentrations in rats at early stages of development 
(first weeks of age) critically depend on dietary protein supply, however this protein 
dependency decreases with age. Condensed, our results suggest that there is an 
effect of protein restriction in utero which generates a high correlation between the 
IGF concentrations and body weight at pre- and early postnatal days, in parts in 
parallel and/or in consequence of litter size. However, in no case these correlations 
were maintained until dpn 188.  
Table 6: Slaughter weight and concentrations of IGF-1 and IGF-2 (means ± SE) of 
piglets from smaller and bigger litter size group at different age. 
mean SE mean SE
dpc 94 Slaughter weight (kg) 0.620 ± 0.03 0.670 ± 0.02
IGF-1 (ng/mL) 16.02 ± 0.76 15.90 ± 0.57
IGF-2 (ng/mL) 25.66 ± 0.73 26.08 ± 0.64
dpn 1 Slaughter weight (kg) 1.406 ± 0.06 1.264 ± 0.05
IGF-1 (ng/mL) 41.08 ± 3.13 28.43 ± 1.79
IGF-2 (ng/mL) 30.26 ± 0.90 27.78 ± 0.95
dpn 28 Slaughter weight (kg) 7.113 ± 0.26 7.702 ± 0.26
IGF-1 (ng/mL) 96.01 ± 7.00 128.7 ± 8.49
IGF-2 (ng/mL) 32.54 ± 0.92 33.60 ± 0.83
dpn 188 Slaughter weight (kg) 129.1 ± 2.14 127.6 ± 1.77
IGF-1 (ng/mL) 219.0 ± 10.3 209.1 ± 7.43
IGF-2 (ng/mL) 39.85 ± 0.70 39.21 ± 0.66
1-12 > 12
Litter size group
 
Abbreviations: SE: standard error, dpn: days post natum, dpc: days post conception. 
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Further correlations were observed for IGF-1 as well as for IGF-2: Both IGFs showed 
correlations with their binding proteins in a similar manner, probably based on their 
similar age-related changes; IGF-1 and IGF-2 were also intercorrelated on dpc 94 
and dpn 28, thus indicating a high association between both IGFs. 
Both IGF-1 and IGF-2 are expressed in fetal tissues, but our results support IGF-2 as 
the primary growth factor supporting fetal growth, as indicated in recent studies 
(Gicquel and Le Bouc, 2006). At day 94 of gestation, protein restricted fetuses had 
lower IGF-2 values and showed lower weights compared to the offspring from AP fed 
dams. While most studies have found no association between serum IGF-2 
concentrations and fetal weight (Fowden, 2003), we could demonstrate an 
association between low fetal body weight and decreased IGF-2 concentration. 
Consequential our findings suggest that there is the same association between IGF-
2, protein restriction in utero and body weight at dpc 94 as mentioned before for IGF-
1 at dpn 1. In agreement with our findings, IGF-2 is considered as being most 
important as fetal growth regulator (DeChiara et al., 1991) and it is thus plausible why 
research in the area of IGF-2 was focused on this aspect (Moses et al., 1980; 
Daughaday et al., 1982; Gluckman and Butler, 1983). 
The average IGF-2 concentrations investigated in our study across all maternal diet 
groups steadily increased from dpc 94 until day 188. The absolute concentrations we 
measured herein markedly differ from those reported in the recent literature about 
IGF-2 concentrations in piglets of approximately the same age (Table 4). This 
divergence likely reflects differences in the assays used in the respective studies. In 
our investigation herein we used a commercial human IGF-2 ELISA (IGF-2 E30, 
Mediagnost®, Reutlingen, Germany) for analysing porcine IGF-2, whereas most of 
the recent investigations used radioimmunoassay for determining IGF-1 and -2 
values in porcine blood (Lee et al., 1991; Lee et al., 1993; Peng et al., 1996). Based 
on the fact that the amino acid sequence of human and porcine IGF-1 is completely 
homologous, and the one of human and porcine IGF-2 differs in only one position, 
i.e. 98.5 % homology (Humbel, 1990), we used these human ELISAs for quantifying 
each IGF in porcine blood. Moreover the parallelism was documented between 
human standard and porcine sample. Thus we can only speculate about the reasons 
of the 2 to 20-fold lower IGF-2 concentrations we assessed in our study as compared 
to the ones from the literature. Noticeably, this divergence was limited to IGF-2 
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whereas the IGF-1 concentrations measured herein were well within the range of 
concentrations reported earlier for pigs at comparable ages. Potentially the binding 
between the human IGF-2 antibodies out of the commercial ELISA and the IGF-2 
molecules in the plasma samples of fetuses and piglets were not as cross-reactive as 
assumed. The binding sites of the antibodies might have been not specific enough 
for recognizing the porcine IGF-2 molecules, but such a difference in binding affinity 
would require differences in the molecular structure of human versus porcine IGF-2, 
albeit this is not probable based on the sequence. What reason really caused this 
difference in absolute concentrations for porcine IGF-2 in all our samples is presently 
not clear. Due to this divergence, our results are not comparable to recent findings 
and we could not attest the preponderance of IGF-2 over IGF-1 in fetal serum in pigs 
as described by Lee et al. (Lee et al., 1991). Nevertheless the validity of our data in 
terms of relative comparisons has been proven in the pilot experiments (3.2.1 page 
22 and 3.2.2 page 22). 
In line with previous studies, we found that protein restriction as modulator has more 
pronounced effects on circulating concentrations of IGF-1 than on IGF-2 (Fowden, 
2003). Besides, IGF-1 and -2 were more affected by protein restriction than by 
protein excess, which is in agreement with the study of Nissen et al. (2005) 
demonstrating that the fetal concentrations of IGF-1 and IGF-2 are not affected by 
maternal feeding above requirements In this context, the findings of Rehfeldt et al. 
(2004) whereupon increased maternal feed does not necessarily result in increased 
nutrient supply to the fetuses, are of relevance. In the present study, primiparous 
sows were used for the experiment of protein excess- and deficit during gestation. 
Schoknecht et al. (1993) showed differences between primiparous and multiparous 
sows for such experiments. In primiparous gilts, maternal growth is continued during 
gestation, whereas in multiparous sows adult size is probably already reached. The 
progeny of primiparous pigs might be expected to be more vulnerable to maternal 
protein restriction than progeny of multiparous dams, given the consequences of 
fetal-maternal competition for nutrients (Schoknecht et al., 1993). Concerning our 
study, the effect of protein deficit during gestation might thus have been amplified for 
the progeny caused on the competing situation for protein supply between the fetus 
and the continuously growing primiparous sows. 
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Schoknecht et al. (1993) focused on the effects of maternal protein deficiency using 
diets of only 0.5% protein throughout the entire pregnancy, on piglet growth. In their 
study growth was consistently affected suggesting that gene expression in the 
progeny controlling long-term postnatal somatic growth is affected adversely only if 
maternal protein insufficiency is extended over all or most phases of prenatal life 
(Schoknecht et al., 1993). However, the protein restriction to 0.5% of the diet is very 
drastic and the components of the IGF-system would probably be significantly 
affected but were not investigated in the study. Nevertheless, in view of the huge 
differences in protein restriction of our study and the one by Schoknecht et al. (1993), 
comparisons with our results are of limited use only. However, the concentrations of 
the IGFs in the fetus with birth weight are reportedly correlated in pigs (Lee et al., 
1993), the latter being knowingly correlated with postnatal growth.  
Sex differences in plasma IGF-1 values were solely observed on dpn 188; for IGF-2 
there were no differences between sexes throughout the study. Owens et al. (1999) 
hypothesized that sex differences in plasma IGF-1 probably reflect those in GH 
secretion and contribute to the sexually dimorphic growth, because IGF-1 promotes 
growth and is GH-responsive (Owens et al., 1999). Metz and Claus (2003) showed 
that barrows in comparison to boars had less GH and significantly lower IGF-1 
concentrations. Consequently, the current observations that male pigs had lower 
IGF-1 concentrations than females albeit the slaughter weights of male and females 
were not significantly different might be attributed to the fact that the male pigs in our 
study were castrated as commonly done to avoid boar taint in porc. Due to this they 
displayed comparatively lower IGF-1 values. No distinct differences between life 
weight at slaughter and hot carcass weight between barrows and sows were 
concordantly reported (Cisneros et al., 1996).  
5.3 IGFBPs 
In adults, decreased nutritional intake and in particular protein restriction reduce the 
plasma concentrations of IGF-1 and also changes the relative concentrations of the 
IGFBPs in plasma (Breier, 1999). For the IGFBPs, indeed nutrient intake has been 
identified as major regulator of their plasma concentrations (Thissen et al., 1994). 
The IGFBPs 1 to 4 are the most prevalent IGFBPs in plasma and tissue, although 
their relative portions vary (Zapf et al., 1990). In response to dietary protein 
Discussion  59 
 
 
 
 
restriction, the concentrations of the various IGFBPs change divergently and not in a 
consistent direction and extent as for example shown in rats (Lemozy et al., 1994). 
In our study IGFBP-1 was affected by maternal protein feeding during gestation on 
dpc 94. We observed an association between maternal protein feeding, IGFBP-1 
values and fetal body weight class. Fetuses from dams fed the excess protein diets 
(HP) had significantly higher IGFBP-1 concentrations and lower fetal body weights 
compared to the other two diet groups. In addition, fetuses of the light fetal body 
weight class, irrespective of the maternal diet, had higher IGFBP-1 values than the 
ones of the higher body weight class. These findings of dpc 94 are not in line with 
results from later postnatal stages: Lemozy et al. (1994) reported that protein 
restriction in young rats increased their IGFBP-1 values , and in newborn pigs fasted 
for 24 h, higher IGFPB-1 concentrations than in fed controls are reported (McCusker 
et al., 1989). Also for long-term dietary restriction, increased IGFBP-1 values are 
reported for human patients (Busby et al., 1988). The latter findings are more 
comparable to the situation we found for neonatal piglets. At this point of 
development we observed a negative correlation between IGF-1 and IGFBP-1; 
piglets from LP fed mothers had higher IGFBP-1 values, while they had significantly 
lower concentrations of IGF-1 than the AP and HP piglets. This negative correlation 
agrees with previous findings in human serum (Rajaram et al., 1997).  
In this investigation piglets from the sows fed a LP diet showed a similarly intensive 
increase of IGFBP-1 values from dpc 94 to dpn 1 as compared to AP piglets, 
whereas the IGFBP-1 concentrations in offspring from HP fed sows remained 
unchanged during this time interval. In view of the mostly inhibitory effects of IGF-1 
on IGFBP-1 reported from cell culture experiments (Thraikill et al., 1990), our results 
do not support such a relation. However, the transition from intra to extra uterine life 
were not addressed in previous studies about the regulation of IGFBP-1 and 
considering the complex and dynamic changes occurring in this phase, the situation 
might well be different. In addition, the possibility that the IGFBP-1 quantified herein 
from the 30 kDa band in the Western Ligand blot system, might actually not be 
entirely specific for IGFBP-1 (McCusker et al., 1989), as mentioned before in 4.3. 
Consistent with a previous study of Peng et al. (1996), we found the highest IGFBP-1 
concentrations at the first day of life. In fact, detection of IGFBP-1 was limited to 
dpc 94 and dpn 1 and the respective band was not displayed at later ages. Lee et al. 
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(1991) detected IGFBP-1 only in postnatal sera, representing only a minor portion of 
total IGF-binding activity in porcine serum. In general, decreasing IGFBP-1 
concentrations from early to later postnatal stages were demonstrated (Lee et al., 
1991; Lee et al., 1993; Peng et al., 1996). Such low concentrations are probably the 
reason why we could not detect IGFBP-1 at days 28 and 188 post natum since the 
sensitivity of the Western ligand blot system we used was obviously not sensitive 
enough. 
The IGFBP-2 concentrations did not differ between sexes, litter size group or birth 
body weight classes on any day of sampling. Based on the fact that the binding 
affinity between IGFBP-2 and IGF-2 is about 3-fold higher than that of IGFBP-2 and 
IGF-1 (Clemmons and Underwood, 1991), and the use of IGF-1 as labeled ligand in 
the Western ligand blot might have resulted in a less sensitive detection of IGFBP-2 
and thereby detection of potential differences for these aforementioned fixed factors 
might have been compromised.  
Nevertheless, the IGFBP-2 values obtained on dpn 1 and dpn 28 of piglets born to 
mothers fed the protein restricted diet during gestation are consistent with a previous 
study in rats, in which IGFBP-2 was decreased during protein restriction (Lemozy et 
al., 1994). Rajaram et al. (1997) hypothesized that nutrition-induced changes in 
serum IGFBP-2 represent the direct effect of dietary protein on IGFBP-2 expression 
in liver, however, this was not assessed in our study and needs further investigation. 
Thraikill et al. (1990) suggested that IGF-1 directly stimulates the secretion of IGFBP-
2, and thus the increased values of IGFBP-2 in HP piglets might be explained, since 
they also had increased concentrations of IGF-1 on dpn 1. The adjustment to similar 
concentrations of IGFBP-2 in all piglets regardless of maternal diet until day 188, 
might have resulted from the postnatal feeding being equal in all groups: in 
undernourished children, protein refeeding normalized the serum IGFBP-2 levels, 
and high-protein intake was required to achieve complete normalization (Pucilowska 
et al., 1993). 
The interaction between body weight at birth and maternal feeding detected on 
dpn 28, showed that piglets born to mothers fed the LP diet with lower birth weights 
had lower IGFBP-2 values on dpn 28 compared to piglets with higher birth weights 
but adequate protein supply during gestation. Piglets born to mothers fed the AP or 
HP diet during gestation and with higher birth weights had reduced IGFBP-2 
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concentrations compared to piglets with lower weight at birth but the same nutrient 
environment in utero. In this case, it is obvious that protein restriction during fetal 
development has a greater impact on the IGFBPs of the offspring than protein 
excess. 
The ontogenetic changes of IGFBP-2 we observed are consistent with reports by Lee 
et al. (1993). In general, we recorded the highest IGFBP-2 values on dpn 1; age 
related differences were observed for all diet groups. The concentration of IGFBP-2 
tended to lowest concentrations on dpn 28 and dpn 188, respectively. Similarly, 
IGFBP-2 increased during the latter half of fetal life in pigs and then gradually 
declined during postnatal development (Lee et al., 1993). 
Our finding that IGFBP-2 represents a major form of IGFBPs in fetal and early 
postnatal porcine plasma, agrees with the one of McCusker et al. (1989). In their 
study, IGFBP-3 was also shown to predominate in later postnatal ages and also in 
maternal porcine plasma, respectively. 
For the IGFBP-3 concentrations, an age related increase was observed in all diet 
groups (Figure 5), whereby the biggest difference between subsequent sampling 
days was from dpn 28 to 188. Comparing dpc 94 and dpn 188, 16-fold higher IGFBP-
3 values were seen on dpn 188. Similar changes, i.e. a 10-fold increase from dpc 90 
to dpn 169 have been demonstrated earlier for IGFBP-3 (Lee et al., 1991; Lee et al., 
1993; Peng et al., 1996). In conclusion, our data do confirm the notion that IGFBP-3 
blood concentrations are low during fetal development and increase thereafter in 
postnatal life. 
Focusing on IGFBP expression in the fetus, the effects of nutritional and endocrine 
conditions in utero have been demonstrated to concern mainly IGFBP-1, -2 and -4 
rather than IGFBP-3 (Fowden, 2003). The lack of maternal diet effects on IGFBP-3 at 
dpc 94 in our study is thus in line with this study. Verified differences related to 
maternal feeding group were limited to dpn 1 when the concentrations of IGFBP-3 in 
HP piglets were significantly higher than in AP piglets. Again, this result agrees with 
the fact that on dpn 1, piglets from litters with less than 12 neonates had higher 
IGFBP-3 values than those from bigger litters, because the piglets out of the smaller 
litters were primarily born to mothers fed the HP diet during gestation.  
In general, serum IGFBP-3 levels are regulated by IGF-1 and GH (Rajaram et al., 
1997), i.e. GH and IGF-1 both induce the synthesis and secretion of IGFBP-3 and 
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thus increase its concentrations in plasma (Clemmons et al., 1989). Our observation 
of higher IGF-1 values in the HP piglets together with higher IGFBP-3 concentrations 
on dpn 1, supports the findings of Rajaram et al. (1997) and Clemmons (1998). The 
apparent coherence between IGF-1 and IGFBP-3 pictured in our findings supports 
the fact that IGFBP-3 is the major carrier of IGF-1 and probably accounts for the 
stability of IGF-1 in blood, as already hypothesized by Clemmons and Underwood in 
1991. 
In contrast, our results could not support a significant reduction in serum IGFBP-3 
concentrations in response to extended fasting and/or protein deficiency as reported 
for adult stages (Clemmons et al., 1989; Lemozy et al., 1994; Smith et al., 1995). 
Possibly this relationship is not or only partially applicable for fetal and neonatal life. 
Consequently, further investigations should clarify this. 
Likewise, refeeding either adequate energy or protein intake will increase the 
concentration of IGFBP-3 (Clemmons et al., 1989). Pertaining to the statement of 
Clemmons et al., our findings of the IGFBP-3 concentrations in HP piglets on dpn 1 
indicate that the preceding high protein supply during fetal life has articulately 
stimulated IGFBP-3 concentrations. Our results definitely support the actuality of 
increased IGFBP-3 concentrations after refeeding as shown in the ontogeny of 
IGFBP-3 in LP piglets. The animals were thus able to compensate their decreased 
IGFBP-3 values in comparison with the other two protein diets when fed adequate 
protein levels in postnatal life, as shown for dpn 28 and dpn 188.  
Detection of IGFBP-4 was limited to dpc 94, dpn 1 and dpn 28. The highest IGFBP-4 
concentrations were detectable on dpn 1, in accordance to reports by Peng et al. 
(1996). In their study, the IGFBP-4 concentrations were increased from dpc 90 to 
highest values on dpn 1 and then decreased again to dpn 21, 90 and 180 reaching 
similar concentrations as during fetal life. In our study, IGFBP-4 was even 
undetectable on dpn 188. 
On none of the sampling days, differences between the diet groups occurred, 
although the plasma concentrations of IGFBP-4, an inhibitor of IGF action, are 
reportedly decreased with undernutrition both in serum and in tissues at the 
transcriptional level (Breier, 1999). IGFBP-4 appears to inhibit IGF actions under 
most, if not all, experimental conditions (Jones and Clemmons, 1995). This actuality 
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is supported by our results: We showed a highly negative correlation between 
IGFBP-4 and IGF-1 over all experimental postnatal days.  
Correlations between the IGFs and the IGFBPs 1-4 on all postnatal days agree with 
previous findings in human serum (Rajaram et al., 1997), where positive correlations 
were limited to the IGF-s and IGFBP-3. For IGFBP-1, IGFBP-2 and IGFBP-4 
negative correlations were detectable. These data suggest that different mechanisms 
may regulate the secretion of the various IGFBPs in humans and also in pigs. 
Nevertheless, the observed interrelationships between the different IGFBPs showed 
a remarkable association between the IGFBPs and thus support their main function 
as principal carrier of the IGFs (Thissen et al., 1994). 
Even though the fetal IGF-1 concentrations were increased in the fetuses of the 
heavier body weight class, the abundance of fetal IGFBPs remained largely 
unaffected, implying that the half life and transport of the IGFs to peripheral tissues 
by IGFBPs might not or only marginally be concerned. 
5.4 IGF-1 receptor 
The availability and thus action of the IGFs are modulated through the high affinity 
binding proteins, whereas the cellular response towards the IGFs is mediated 
through their receptors, which are present on virtually all cell types (Thissen et al., 
1994). The IGF-1 receptor mediates most of the effects of IGFs (Collett-Solberg and 
Cohen, 2000). We limited our measurements of the IGF-1 receptor in the fetuses and 
piglets from our study to liver tissue since the liver is considered as the principal 
source of circulating IGFs (Yakar et al., 2002). However, the concentrations of IGF-1 
receptor in liver at any of the postnatal samples were below the limit of detection of 
the assay available. For the fetal stage, the concentrations across all diet groups 
were within the measuring range of the assay. For the mRNA expression of the IGF-
1 receptor, Lee et al. (1993) reported that the hepatic mRNA abundance in pigs did 
not change during the second half of fetal life, then declined by day 21 post natum, 
and further to nearly undetectable levels by day 170. Our results seem to support 
their mRNA findings of the IGF-1 receptor ontogenesis, coincident with results 
previously found in rats (Alexandrides et al., 1989; Werner et al., 1989). Neither 
maternal feeding group nor body weight nor litter size nor sex apparently influenced 
IGF-1 receptor content on dpc 94 in liver, which indicates that different protein diets 
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in utero throughout the entire pregnancy might rather act at the level of the ligand 
than of the receptor, if the IGF-system is concerned at all.  
5.5 Body composition at the postnatal days 
Body weight and components of body composition are highly associated with the 
IGF-system and leptin, as modulators of growth and development (Fowden and 
Forhead, 2004). In pigs, body weight and composition are influenced due to 
inadequate protein supply in utero (Rehfeldt et al., 2011b). At their first day of life, 
piglets exposed to maternal LP diet in utero had lower body and hot carcass weights 
compared to the AP piglets. In line with this, piglets of the lighter birth weight class, 
mainly born to LP fed gilts, showed lower slaughter and hot carcass weights, too. 
Likewise Rehfeldt et al. (2011b) showed significantly reduced body and hot carcass 
weights on dpn 1 in LP piglets in an experiment with the same dietary treatments as 
in this study. These results are in line with further previous studies, in which body 
weight at birth was significantly lower in progeny of dams fed a protein-deficit diet 
with 0.5% protein throughout pregnancy compared to progeny of control dams 
(Atinmo et al., 1974; Pond et al., 1991; Schoknecht et al., 1993). As potential reason 
for impaired fetal growth resulting in significantly reduced birth body weights the 
deficit mainly of essential amino acids in response to LP feeding in utero is 
considered. Beside essential amino acids, aberrant concentrations of other 
hormones such as insulin, leptin and IGF-1 might form additional causal factors for 
the fetal growth retardation in LP offspring (Rehfeldt et al., 2011a). Our data at least 
partially support this hypothesis indicating a relationship between reduced birth 
weight and decreased leptin and IGF-1 concentrations on dpn 1 in piglets born to LP 
fed gilts during gestation. In addition, we detected positive correlations between IGF-
1 and all three weight parameters (birth weight, slaughter weight and hot carcass 
weight) as well as between leptin and all three weight variables on dpn 1.  
The highly positive correlation between body weight, hot carcass weight and 
slaughter weight, observed for all three diet groups on dpn 1 explains for the logic 
coherence, why the low birth weight piglets exhibited lower slaughter and hot carcass 
weights on dpn 1. Moreover, the reduced slaughter and hot carcass weights of 
piglets born to gilts fed the low protein diet were to be expected according to previous 
studies (Pond et al., 1992; Davis et al., 1997) in which piglets of protein restricted 
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dams exhibited reduced birth weights, too. In the current report, for both variables, 
slaughter and hot carcass weights, piglets of greater litters showed lower weights. 
These results can be interpreted as consequences of reduced birth weights of large 
litters which are in turn attributable to the reduced space per fetus in utero (Foxcroft 
et al., 2006). 
The composition of the whole body in terms of protein, lipid and ash contents 
obtained by chemical analysis was not significantly changed by dietary treatment in a 
similar study (Rehfeldt et al., 2011b), whereas we observed significantly lower lipid 
percentages for piglets of lower birth weights at dpn 1. Interestingly, there was no 
evidence for a correlation between birth weight and analytical lipid percentage 
observed on dpn 1.  
For the percentages of protein and dry matter, an interaction between diet and litter 
size group was detectable. The greater litters showed lower values of protein and dry 
matter in response to the HP diet in utero, whereas the AP and LP diet did not affect 
the protein or dry matter percentage in different litter size groups. The reasons for 
these interrelations are not clear. 
Grippingly, for all postnatal days significant differences of slaughter weights and hot 
carcass weights between the birth weight classes were observed. As a matter of 
course, pigs with higher weights at birth had significantly higher slaughter weights 
and hot carcass weights on dpn 28 and dpn 188 compared to piglets with lower 
weights at birth. The maternal low protein diet did not affect slaughter or hot carcass 
weight of the offspring on dpn 28 or 188, showing that the decrease in birth weight, 
found in LP pigs was compensated during postnatal life. Nevertheless, our results 
show an indirect relation between reduced birth body weights due to the LP diet in 
utero and the reduced slaughter and hot carcass weights on dpn 28 and 188, 
because verifiably piglets with low birth weights were mainly from the dams fed the 
LP diet during gestation. Regarding these findings we hypothesize that porcine 
fetuses that are exposed to a protein restriction in utero will have significantly 
reduced birth weight and will not be able to entirely compensate this protein deficit 
thus remaining in a growth retarded state in their later life. The stunting effect of 
maternal protein restriction throughout gestation on postnatal development of 
progeny was expected, based on previous observations (Pond et al., 1969; Atinmo et 
al., 1974; Atinmo et al., 1976). In addition Rehfeldt et al. (2008) reported that low 
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birth weight piglets grew distinctly slower than middle and heavy birth weight piglets 
and exhibited the lowest postnatal growth performance. 
On dpn 28, exclusively fat and dry matter content were affected by maternal feeding, 
litter size and birth weight. Lipid and dry matter content were higher in piglets born to 
LP fed mothers than in HP and AP piglets. These results are again consistent with 
the findings of Rehfeldt et al (2011b) where the carcasses of LP pigs had increased 
lipid percentages in whole empty body on dpn 28. These recent findings of Rehfeldt 
et al. support our findings albeit they were reported in pigs at market weight. In this 
study, pigs of low birth weight exhibited the lowest lean mass and the highest degree 
of fatness and thus lower carcass quality compared with pigs of higher birth weights 
(Rehfeldt et al., 2008). To confirm this hypothesis, more body composition traits, 
especially lean mass, perirenal fat and back fat thickness should be evaluated.  
For lipid and dry matter percentage, there was an interaction between diet and litter 
size group on dpn 28: HP piglets showed higher lipid percentages in smaller litters, 
whereas LP and AP piglets showed lower lipid percentages in smaller litters. The 
same interaction between diet and litter size group was observed for carcass protein 
and fat content on dpn 188. In this case, AP pigs differed from HP and LP pigs. AP 
pigs exhibited higher chemical lipid percentages in smaller litters as compared to HP 
and LP pigs that displayed lower lipid portions in smaller litters. The interaction 
between diet and litter size group for carcass protein was displayed as follows: AP 
pigs had lower carcass protein values corresponding to smaller litters, whereas HP 
and LP pigs displayed higher protein percentages in smaller litters. What in detail 
causes this interaction between diet and litter size for different analytical components 
of the whole empty body is not known yet.  
The effects of sex on the percentages of protein, fat and dry matter of the whole 
empty body on dpn 188 are in compliance with findings of Schoknecht et al. (1993) 
and Rehfeldt et al. (2008). They reported that females had higher lean percentages 
than male castrates (Rehfeldt et al., 2008) and female carcasses were significantly 
lighter and leaner, with less back fat at the ribs, greater trimmed ham and loin, lower 
belly weight compared to carcasses of castrated males (Schoknecht et al., 1993). 
Again, more detailed data on body composition and carcass quality as for example 
provided by Rehfeldt et al. (2011b) might help to detect interrelationships not visible 
so far. 
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5.6 Conclusion 
In the present study we tested the effects of protein deprivation and protein excess 
throughout pregnancy on the offspring. As a contribution to basic research, this 
approach is relevant for pig production even though such large variations in protein 
content are not targeted during routine procedures of pig farming. Nevertheless the 
effects of such deflections contribute to our understanding of nutrient regulation 
during fetal life. Moreover, the animal experiment provides an interesting model for 
humans. As obvious from recent studies, using the pig model for studying biological 
interrelationships and pathways in humans provides several advantages. 
The notion of a sort of ‘diet memory’ initiated by inadequate nutrient supply during 
intra-uterine life resulting in impaired or altered endocrine or bodily functions or 
performance in adulthood is not comprehensively supported by the present study. All 
statistically sound effects of inadequate protein diets during gestation were limited to 
prenatal and early postnatal days. Furthermore, the provable effects were 
predominantly arising from protein restriction in utero. Protein excess did not or only 
scarcely exert short or long term effects on all factors tested in our investigation. The 
reasons for this are not entirely clear. One can assume that the observed effects of 
protein restriction on the variables investigated herein reflect the competing situation 
of protein supply between fetuses and the primiparous sow. It should be investigated 
in further studies if the results of this study are repeatable in multiparous sows under 
the same conditions. Alternatively, the extent of protein restriction might be a reason 
for the marginal effects. Due to the fact that a protein restriction of 0.5% during 
gestation showed multiple consequences on the offspring, as shown by Schoknecht 
et al., 1993, it could be speculated that perhaps a protein restriction of 6% was not 
severe enough to influence the fetal nutrient environment as extensive as it was 
expected. Moreover, in recent studies in which protein restriction was realized 
throughout gestation and where clear effects of this restriction were observed 
(Schoknecht et al., 1993), the offspring was not cross fostered after birth as in our 
study, but rather suckled by their dams. Although these piglets had free excess to a 
standard preweaning starter diet, the colostrums of their dams could probably amplify 
the effects of the protein restriction of their dams during gestation. The reason of our 
cross-fostering-model was to focus exclusively on the long term effects of protein 
excess- and deficit throughout pregnancy, but exclude effects of potentially divergent 
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nutrient supply during the weaning period. The sows serving as foster mothers had 
received adequate protein supply before and during lactation. This situation seemed 
to cause a sort of catch up possibility for the in utero impaired offspring, immediately 
after birth. Based on our cross-fostering-model it seems obvious that the possible 
long term effects of the modified nutritional environment in utero could be attenuated 
by the possibility of catching up directly after birth.  
In summary, the present work showed that the IGF-system and leptin in progeny 
were sparsely swayed by inadequate protein supply during gestation at different 
stages of ontogeny. Leptin seemed to be insignificantly regulated by the protein 
content in the maternal diets and accordingly we could not detect long term 
consequences on leptin concentrations. For the IGFs, nutrient restriction as 
modulator had more pronounced effects on circulating concentrations of IGF-1 than 
on IGF-2. The present study revealed an apparent connection between reduced birth 
weights and aberrant respectively decreased concentrations of IGF-1 and leptin in 
piglets born to mothers fed LP diet throughout pregnancy. Based on our findings, it 
seems that leptin and IGF-1 were additional causal factors for fetal growth 
retardation, at least in LP offspring. For the IGFBPs, only short time effects of protein 
restriction were detectable; IGF-1 receptors in liver were not even affected during 
fetal age. The result of marginal alterations that were mainly restricted to early ages 
and were apparently compensated at later ages, is valid only for the ages studied. It 
remains open whether alterations might emerge at later ages and whether other 
regulative systems might have been affected. In consequence, even though we did 
not observe major and persistent deviations, general recommendations should 
adhere to aim for providing all prerequisites for an optimal intrauterine environment.  
The present study within this thesis was limited to endocrine regulatory changes, in 
particular within the IGF-system. However, the multifaceted approach of the present 
animal study in which epigenetic, metabolic and transcriptomic techniques were used 
in other related projects beyond the scope of this thesis and will yield additional 
information once a circumspect and comprehensive analysis of all data can be done. 
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6 Summary 
Healthy and normal weight piglets preferable with consistent genetics, which yield 
carcasses by efficient feed conversion, are requested from the pig industry. Reduced 
survival and compromised postnatal development due to low birth weight imply 
economic losses for the pig farmers. Size at birth, reflecting fetal growth and 
development, is an important predictor of perinatal survival and adult health in pigs. 
Fetal growth is a complex process that depends on the genotype and epigenotype of 
the fetus, maternal nutrition, the availability of nutrients and oxygen to the fetus. The 
IGF-system as well as leptin are knowingly affected by intrauterine growth 
retardation. In consequence some of these alterations may lead to permanent 
pathological programming of the IGF-system and/or energy homeostasis with energy 
balance and lipid metabolism, in which leptin plays a key role.  
The aim of this dissertation was to characterize leptin and the different components 
of the IGF-system in offspring of sows fed diets with different protein contents 
throughout pregnancy. Furthermore we wanted to identify relationships between the 
different target endocrine components and to evaluate potential long-term 
consequences of maternal diet, endocrine deflections and body growth patterns 
caused by this nutritional fetal programming.  
For this purpose, gilts of the German Landrace were fed gestation diets containing a 
low (LP, 6%), an adequate (AP, 12%), or a high (HP, 30%) protein level. Twenty six 
gilts and their offspring were investigated for sampling at day 94 of gestation. At 
parturition the offspring of the remaining 52 gilts were cross fostered to nursing sows 
fed a 12% protein gestation diet and then a standard lactation diet. Fetal and birth 
weights of the whole investigated offspring were recorded and classified into two 
different fetal body weight classes and two birth body weight classes (Fbwc ≤ or > 
0.65; Bbwc ≤ or > 1.3 kg). In addition, the litter size of any gilt was classified into two 
groups (Lsgr ≤ or > 12 piglets). Blood and liver samples of overall 306 piglets were 
collected. In detail, samples from fetuses of day 94 of gestation, from the 1st day of 
life, 28th day of life (weaning piglets) and the 188th day of life (pigs at marked weight) 
were collected.  
At first, blood samples were assessed by an in house developed ELISA for leptin, 
that has extensively validated for porcine plasma. In samples obtained during fetal 
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life, i.e. on dpc 94, leptin could not be assessed since the concentrations were mostly 
below the assay`s limit of detection. In the offspring over all postnatal days the three 
different protein levels in the maternal diets had no effect on the concentrations of 
leptin. These findings suggest that potential prenatal differences in leptin plasma 
concentrations which may have resulted from intra uterine protein deficit or excess, 
are possibly compensated by the homogenous and adequate protein supply through 
milk from the foster sows in the early postnatal days. However, we observed a 
positive correlation between leptin and body fat content for the piglets on dpn 1 and 
dpn 28, and also a positive correlation between leptin and slaughter weight at these 
two postnatal days. These findings indicate that there was a short time effect of the 
different intrauterine environments on fat content and body weights of the offspring, 
but these effects were not maintained until later adolescent stages. In this study, 
leptin was not as highly correlated to body composition traits, in particular fat 
percentage of the whole empty body, as might have been expected. 
The main components of the IGF-system are the ligands, i.e. IGF-1 and -2. They 
were quantified in the blood plasma samples using commercially available ELISA for 
the human proteins, after securing their applicability for porcine samples. In contrast 
to leptin, the IGF-1 concentrations were well detectable in fetal samples. With the 
exception of dpn 1, the IGF-1 concentrations remained unchanged in response to 
maternal dietary treatments. At dpn 1, the piglets born to mothers fed the LP diet with 
only 6% protein during gestation had significantly decreased IGF-1 concentrations 
compared to piglets born to mothers fed the 30% protein diet and tended to have 
lower IGF-1 values than piglets born to mothers fed an adequate protein diet during 
gestation. In parallel with the results of the IGF-1 concentrations in LP piglets on 
dpn 1, the present investigation also revealed significantly lower IGF-1 
concentrations in piglets of lower birth weight, when compared to the higher birth 
weight. As expected, the piglets born to mothers fed the low protein diet had lower 
slaughter weights than the AP and HP piglets. Consequently, we could demonstrate 
a positive correlation between the IGF-1 concentrations and the body weights of the 
piglets at dpn 1. Moreover, we showed that piglets from smaller litters had higher 
concentrations of IGF-1 on dpn 1 as compared to piglets born to greater litters. This 
observation is in line with the fact that the piglets from smaller litters also had higher 
slaughter weights than piglets out of greater litters. Condensed, our results suggest 
Summary  71 
 
 
 
 
that there is an effect of protein restriction in utero which generates a high correlation 
between the IGF concentrations and body weight at pre- and early postnatal days, in 
parts in parallel and/or in consequence of litter size. However, in no case these 
correlations were maintained until dpn 188.  
Further correlations were observed for IGF-1 as well as for IGF-2: Both IGFs showed 
correlations with their binding proteins in a similar manner, probably based on their 
similar age-related changes; IGF-1 and IGF-2 were also correlated on dpc 94 and 
dpn 28, thus indicating a high association between both IGFs. 
The IGF-1 and IGF-2 are equally expressed in fetal tissues, but our results support 
IGF-2 as the primary growth factor supporting embryonic growth. We could 
demonstrate an association between low fetal body weight and decreased IGF-2 
concentration. In concequence, our results suggest that there is the same 
association between IGF-2, protein restriction in utero and body weight at dpc 94 as 
mentioned before for IGF-1 at dpn 1. The IGF-2 is considered as being most 
important for fetal growth regulation. Nevertheless we found that protein restriction as 
modulator has more pronounced effects on circulating concentrations of IGF-1 than 
on IGF-2. Besides, IGF-1 and -2 were more affected by protein restriction than by 
protein excess.  
In view of the important role of the IGF binding proteins within the IGF-system, a 
semi-quantitative, nonradioactive Western ligand blot was established and validated 
to assess their abundance in the plasma samples.  
In our study IGFBP-1 was affected by maternal protein feeding during gestation on 
dpc 94. We observed an association between maternal protein feeding, IGFBP-1 
values and fetal body weight class. Fetus from dams fed the excess protein diets 
(HP) had significantly higher IGFBP-1 concentrations and lower fetal body weights 
compared to the other two diet groups. In addition, fetuses of the light fetal body 
weight class, irrespective of the maternal diet, had higher IGFBP-1 values than the 
ones of the higher body weight class. Piglets from the sows fed a LP diet showed a 
similarly intensive increase of IGFBP-1 values from dpc 94 to dpn 1 as compared to 
AP piglets, whereas the IGFBP-1 concentrations in offspring from HP fed sows 
remained unchanged during this time interval. We found the highest IGFBP-1 
concentrations at the first day of life. In fact, detection of IGFBP-1 was limited to 
dpc 94 and dpn 1 and the respective band was not displayed at later ages. 
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The secretion of IGFBP-2 is directly stimulated by IGF-1, and thus the increased 
values of IGFBP-2 in HP piglets might be explained, since they also had increased 
concentrations of IGF-1 on dpn 1. The adjustment to similar concentrations of 
IGFBP-2 in all piglets regardless of maternal diet until day 188, might have resulted 
from the postnatal feeding being equal in all groups. The interaction between body 
weight at birth and maternal feeding detected on dpn 28, showed that piglets born to 
mothers fed the LP diet with lower birth weights had lower IGFBP-2 values on dpn 28 
compared to piglets with higher birth weights but adequate protein supply during 
gestation. Piglets born to mothers fed the AP or HP diet during gestation and with 
higher birth weights had reduced IGFBP-2 concentrations compared to piglets with 
lower weight at birth but the same nutrient environment in utero. In this case, it is 
obvious that protein restriction during fetal development has a greater impact on the 
IGFBPs of the offspring than protein excess. 
Verified differences related to maternal feeding group were limited to dpn 1 when the 
concentrations of IGFBP-3 in HP piglets were significantly higher than in AP piglets. 
This result agrees with the fact that on dpn 1, piglets from litters with less than 12 
neonates had higher IGFBP-3 values than those from bigger litters, because the 
piglets out of the smaller litters were primarily born to mothers fed the HP diet during 
gestation. In general, serum IGFBP-3 levels are regulated by IGF-1 and GH, which 
both induce the synthesis and secretion of IGFBP-3 and thus increase its 
concentrations in plasma. In compliance we observed higher IGF-1 values in the HP 
piglets together with higher IGFBP-3 concentrations on dpn 1. This apparent 
coherence between IGF-1 and IGFBP-3 supports the fact that IGFBP-3 is the major 
carrier of IGF-1 and probably accounts for the stability of IGF-1 in blood.  
On none of the sampling days, differences between the diet groups occurred related 
to IGFBP-4 concentrations. IGFBP-4 appears to inhibit IGF actions, which we could 
support by our results: We showed a highly negative correlation between IGFBP-4 
and IGF-1 over all experimental postnatal days. 
As the last part of the IGF-system and as the main target receptor, IGF-1 receptor 
was measured in liver tissue with a commercially available ELISA for human IGF-1 
receptor that was also preliminarily tested for its applicability in porcine liver samples. 
Neither maternal feeding group nor fetal body weight nor litter size nor sex apparently 
influenced IGF-1 receptor content on dpc 94 in liver, which was the only point of 
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development were we could verify the IGF-1R. This ascertainment indicates that 
different protein diets in utero throughout the entire pregnancy might rather act at the 
level of the ligand than of the receptor, if the IGF-system is at all concerned. 
In addition, body weight and also components of body composition are 
influenced due to inadequate protein supply in utero. At their first day of life, piglets 
exposed to maternal LP diet in utero had lower body and hot carcass weights 
compared to the AP piglets. In line with this, piglets of the lighter birth weight class, 
mainly born to LP fed gilts, showed lower slaughter and hot carcass weights, too. As 
potential reason for impaired fetal growth resulting in significantly reduced birth body 
weights the deficit mainly of essential amino acids in response to LP feeding in utero 
is considered. Beside essential amino acids, aberrant concentrations of other 
hormones such as insulin, leptin and IGF-1 might form additional causal factors for 
the fetal growth retardation in LP offspring. Our data at least partially support this 
hypothesis indicating a relationship between reduced birth weight and decreased 
leptin and IGF-1 concentrations on dpn 1 in piglets born to LP fed gilts during 
gestation. The maternal low protein diet did not affect slaughter or hot carcass weight 
of the offspring on dpn 28 or 188, showing that the decrease in birth weight, found in 
LP pigs was compensated during postnatal life. 
In conclusion, the results of this study show clearly, that all ascertained effects of 
modified protein content in diets fed during gestation were limited to prenatal and 
early postnatal days. Furthermore, the provable effects were predominantly arising 
from protein restriction in utero. Protein excess did not or only scarcely affect short or 
long term effects on all factors tested in our investigation. It could be speculated that 
the absent, probably expected, effects are caused on the cross fostering of the in 
utero impaired piglets, directly after birth. This situation caused a sort of catch up 
possibility for the offspring, which probably resulted in adjustment of the impaired 
endocrine and metabolic situation during prenatal and early postnatall stages. 
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7 Zusammenfassung 
In der Schweinefleischproduktion werden gesunde Ferkel mit möglichst einheitlicher 
Genetik nachgefragt, die problemlos, bei guter Futterverwertung, die vom Markt 
gewünschten Schlachtkörpergewichte und -qualitäten erreichen. Ferkelsterben und 
beeinträchtigte postnatale Entwicklung, zurückzuführen auf ein zu geringes 
Geburtsgewicht, bedeuten für den Ferkelerzeuger und auch den Schweinemäster 
wirtschaftliche Einbußen und Verluste. Das Geburtsgewicht, das das fötale 
Wachstum und die fötale Entwicklung wiederspiegelt, spielt eine wichtige Rolle zur 
Vorhersage der Überlebenswahrscheinlichkeit der neugeborenen Ferkel und für die 
Gesundheit der adulten Schweine. Fötales Wachstum ist ein komplexer Prozess, der 
vom Genotypen und Epigenotypen des Fötus, der maternalen Ernährung und der 
Verfügbarkeit von Nährstoffen und Sauerstoff für den Fötus abhängig ist. Man weiß 
bereits, dass das IGF-System genau wie auch Leptin durch die intrauterine 
Wachstumsretardierung beeinträchtigt wird. Einige dieser Veränderungen könnten 
somit eine permanente pathologische Programmierung des IGF-Systems und/oder 
der Energiehomöostase mit Energiebilanz und Fettmobilisierung hervorrufen, in der 
Leptin eine Schlüsselrolle spielt. 
 
Das Ziel dieser Arbeit lag darin, Leptin und die verschiedenen Komponenten des 
IGF-Systems in den Nachkommen von Sauen zu charakterisieren, die während der 
Trächtigkeit mit Rationen unterschiedlichen Proteingehaltes gefüttert worden waren. 
Außerdem wollten wir Beziehungen zwischen den verschiedenen endokrinen 
Zielparametern bestimmen, genauso wie eventuell auftretende 
Langzeitkonsequenzen und endokrine Veränderungen und Abweichungen in der 
Wachstumsstruktur der Nachkommen untersuchen. 
 
Zu diesem Zweck wurden Jungsauen der Deutschen Landrasse während ihrer 
Trächtigkeit mit Diäten unterschiedlichen Proteingehaltes gefüttert. Die Proteindiäten 
unterschieden sich durch 6% Protein (Niedrigproteindiät), 30% Protein 
(Hochproteindiät) und 12% Protein (Adäquatproteindiät). Es wurden Proben der 
Nachkommen von 26 Jungsauen am 94. Trächtigkeitstag genommen und untersucht. 
Am Tag der Geburt wurden die Nachkommen der verbliebenen 52 Jungsauen zu 
Ammensauen umgesetzt, die während ihrer Trächtigkeit eine Diät mit 12% Protein 
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bekommen hatten und von da ab eine standardisierte Laktationsdiät bekamen. Das 
Fötal- und Geburtsgewicht aller Nachkommen wurde festgehalten und in zwei fötale 
Körpergewichtsklassen (≤ 0,65 kg >) und zwei Geburtsgewichtsklassen (≤ 1,3 kg >) 
eingeteilt. Außerdem wurde die Wurfgruppengröße jeder Jungsau in zwei Gruppen 
klassifiziert (≤ 12 >). Blut- und Leberproben der insgesamt 306 Ferkel wurden 
gesammelt. Im Einzelnen wurden Proben von Föten des 94. Gestationstages (dpc 
94), des ersten Lebenstages (dpn 1), des 28. Lebenstages (dpn 28) und des 188. 
Lebenstages (dpn 188) untersucht. 
 
Zuerst wurden die Blutproben in einem Leptin ELISA gemessen, der bereits 
hausintern entwickelt war und für diese Arbeit intensiv für porcines Plasma validiert 
wurde. In den fötalen Blutproben von dpc 94 konnte die Leptinkonzentration nicht 
bestimmt werden, da diese unterhalb der Nachweisgrenze des Testsystems lag. An 
den postnatalen Tagen war kein Einfluss durch die drei verschiedenen 
Proteingehalte in der Fütterung der Jungsauen während der Trächtigkeit auf die 
Leptinkonzentration im Blut der Nachkommen erkennbar. Die Ergebnisse deuten 
darauf hin, dass potentielle pränatale Unterschiede in der Plasmaleptinkonzentration, 
bedingt durch die intrauterine Unter- bzw Überversorgung mit Protein, 
möglicherweise durch die homogene und adäquate Proteinversorgung nach der 
Geburt über die Milch der Ammenmutter kompensiert werden konnte. Trotzdem 
wurde an dpn 1 und 28 eine positive Korrelation zwischen Leptin und dem Fettgehalt 
des Schlachtkörpers ermittelt. Außerdem gab es an diesen beiden Tagen eine 
positive Korrelation zwischen der Leptinkonzentration und dem Schlachtgewicht der 
Ferkel. Diese Ergebnisse belegen eine kurzzeitige Beeinflussung des Fettgehaltes 
und des Körpergewichtes der Nachkommen durch die unterschiedliche, intrauterine 
Nährstoffumgebung. Diese Effekte blieben nicht bis zum adulten 
Entwicklungsstadium bestehen. Desweiteren zeigen unsere Ergebnisse, dass Leptin 
nicht so deutlich mit der Körperzusammensetzung, insbesondere dem Fettgehalt des 
vollständig leeren Schlachtkörpers korreliert ist, wie es erwartet wurde.  
 
Die Hauptkomponenten des IGF-Systems, die Liganden IGF-1 und IGF-2 wurden im 
Plasma mit Hilfe eines kommerziell erhältlichen, humanen ELISA quantifiziert. Durch 
eine fundierte Evaluierung wurde sichergestellt, dass dieser humane ELISA auch für 
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den Nachweis von porcinem IGF-1 und IGF-2 im Plasma geeignet ist. Im Gegensatz 
zu Leptin waren beide Liganden auch im fötalen Plasma nachweisbar. Mit Ausnahme 
von dpn 1 blieb die Konzentration des IGF-1 im Plasma in Bezug auf die maternalen 
Diätgruppen unverändert. An dpn 1 hatten die Nachkommen der Niedrigproteinsauen 
signifikant geringere IGF-1 Konzentrationen im Vergleich zu den Ferkeln der 
Hochproteinsauen und auch tendenziell niedrigere IGF-1 Konzentrationen im 
Vergleich zu den Ferkeln von Müttern die während der Trächtigkeit adäquate 
Mengen an Protein gefüttert bekommen hatten. Gleichzeitig mit den Ergebnissen für 
die IGF-1 Konzentration in den Niedrigproteinferkeln an dpn 1, konnte die 
vorliegende Untersuchung signifikant niedrigere IGF-1 Konzentrationen in den 
Ferkeln mit geringerem Geburtsgewicht, im Vergleich zu den Ferkeln mit höheren 
Geburtsgewicht, zeigen. Wie erwartet, hatten die Ferkel der Niedrigproteinsauen 
auch geringere Schlachtgewichte als die Nachkommen den Hochproteinsauen und 
der Mütter mit adäquater Proteinversorgung während der Trächtigkeit. Folglich 
konnten wir einen positiven Zusammenhang zwischen den IGF-1 Konzentrationen 
und den Körpergewichten der Ferkel an dpn 1 offenlegen. Darüber hinaus konnten 
wir an dpn 1 zeigen, dass Ferkel aus kleineren Würfen (≤ 12) höhere 
Konzentrationen an IGF-1 im Vergleich zu Ferkeln aus größeren Würfen aufwiesen. 
Diese Feststellung stimmt mit der Tatsache überein, dass die Ferkel aus kleineren 
Würfen ebenso größere Schlachtgewichte aufzeigten als Ferkel aus größeren 
Würfen. Zusammengefasst suggerieren unsere Resultate einen Einfluss der 
intrauterinen Proteinrestriktion auf die Nachkommen, der sich deutlich in der hohen 
Korrelation zwischen der IGF-1 Konzentration und den Körpergewichten an den 
pränatalen und frühen postnatalen Tagen zeigt und in Teilen auch parallel dazu in 
Konsequenz der Wurfgruppengröße deutlich wird. Allerdings war keine dieser 
Korrelationen bis zum Tag 188 beständig. Für beide Liganden des IGF-Systems, 
IGF-1 und IGF-2, konnten wir weitere Korrelationen ermitteln: Beide IGFs zeigten 
dieselben Korrelationen mit ihren Bindungsproteinen, was sich wahrscheinlich durch 
dieselben, altersbezogenen Veränderungen begründen lässt. Außerdem waren IGF-
1 und IGF-2 an dpc 94 und an dpn 28 miteinander korreliert, was eine sehr hohe 
Assoziation zwischen den beiden Molekülen bezeichnet. Im fötalen Gewebe werden 
IGF-1 und IGF-2 gleichmäßig exprimiert, aber unsere Ergebnisse bestätigen 
wiederum IGF-2 als hauptsächlichen Wachstumsfaktor des embryonalen 
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Wachstums. Wir konnten außerdem eine Assoziation zwischen niedrigem fötalen 
Körpergewicht und reduzierter IGF-2 Konzentration beweisen. Daraus folgend ergibt 
sich an dpc 94 der gleiche Zusammenhang zwischen der intrauterinen 
Proteinrestriktion, der IGF-2 Konzentration und dem fötalen Körpergewicht, wie wir 
vorher schon für IGF-1 an dpn 1 anführen konnten. Auch wenn IGF-2 als wichtigster 
fötaler Wachstumsfaktor betrachtet wird, konnten wir beweisen, dass bei 
regulatorischer Proteinrestriktion IGF-1 mehr als IGF-2 beeinflusst wird. Überdies 
wurden beide Liganden mehr durch die intrauterine Proteinrestriktion als durch den 
intrauterinen Proteinüberschuss beeinflusst. 
 
Begründet durch die ebenso wichtige Rolle der IGF Bindungsproteine im IGF-
System, wurde ein semiquantitativer, nichtradioaktiver Western Liganden Blot 
etabliert und validiert. Mit diesem Western Liganden Blot wurde die Menge der 
einzelnen Bindungsproteine im Plasma bestimmt.  
Das IGFBP-1 im Plasma der fötalen Nachkommen war durch die maternale, 
intrauterine Fütterung beeinflusst. Wir konnten einen Zusammenhang zwischen der 
maternalen Fütterungsgruppe, dem Gehalt an IGFBP-1 und der fötalen 
Körpergewichtsklasse feststellen. Föten von Müttern, die während der Trächtigkeit 
einen Überschuss an Protein bekommen hatten, hatten signifikant höhere IGFBP-1 
Konzentrationen und ein geringeres Körpergewicht im Vergleich zu den 
Nachkommen der anderen beiden Diätgruppen. Zusätzlich wiesen die Föten der 
leichteren Körpergewichtsklasse, unabhängig von der maternalen Fütterungsgruppe, 
höhere Mengen an IGFBP-1 im Plasma auf. Ferkel der Niedrigproteinsauen zeigten 
im Vergleich zu den Nachkommen der Mütter, die die adäquate Proteindiät während 
der Trächtigkeit bekommen hatten, einen gleichstarken Anstieg an IGFBP-1 von dpc 
94 bis dpn 1, wohingegen die Konzentration an IGFBP-1 in den Nachkommen der 
Hochproteinsauen in diesem Zeitraum nahezu unverändert blieb. Wir konnten die 
höchsten Konzentrationen an IGFBP-1 an dpn 1 feststellen. Tatsächlich war die 
Messung im Plasma nur an dpc 94 und dpn 1 möglich, da zu den späteren 
Probentagen keine dementsprechende Bande im Western Liganden Blot detektiert 
werden konnte.  
Die Sekretion des IGFBP-2 wird direkt durch IGF-1 stimuliert, wodurch die erhöhten 
Mengen an IGFBP-2 in den Nachkommen der Hochproteinsauen am ersten 
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Lebenstag erklärt werden könnten, da diese zu diesem Zeitpunkt auch erhöhte IGF-1 
Konzentrationen aufwiesen. Die Adaption bis zum dpn 188 an gleiche IGFBP-2 
Konzentrationen aller Nachkommen, ungeachtet welche Proteindiät die Mutter in der 
Trächtigkeit erhalten hatte, könnte durch die gleiche Fütterung aller Nachkommen ab 
der Geburt begründet sein. Die an dpn 28 festgestellte Wechselbeziehung zwischen 
dem Geburtsgewicht und der maternalen Fütterungsgruppe verdeutlichte, dass die 
Nachkommen der Niedrigproteinsauen mit niedrigeren Geburtsgewichten niedrigere 
Gehalte an IGFBP-2 aufwiesen als die Nachkommen mit höherem Geburtsgewicht 
und adäquater intrauteriner Proteinversorgung. Schwerere Nachkommen der mit 
Protein adäquat- und überversorgten Sauen hatten reduzierte Konzentrationen an 
IGFBP-2 im Vergleich zu Ferkeln mit geringerem Geburtsgewicht aber der gleichen 
intrauterinen Nährstoffumgebung. Durch diese Ergebnisse ist offensichtlich, dass 
Proteinrestriktion einen größeren Einfluss auf die IGF Bindungsproteine hat als 
intrauteriner Proteinüberschuss. 
Die offensichtlichen Einflüsse der maternalen Diät auf das IGFBP-3 waren auf dpn 1 
reduziert. Hier war die Konzentration an IGFBP-3 in den Nachkommen der 
Hochproteinsauen signifikant höher als in den Nachkommen der 
Adäquatproteinsauen. Das wiederum stimmt mit der Tatsache überein, dass an dpn 
1 Ferkel aus kleineren Würfen höhere IGFBP-3 Konzentrationen im Blut aufwiesen 
als die Ferkel aus größeren Würfen, da die Ferkel aus den kleineren Würfen 
hauptsächlich Nachkommen der Hochproteinsauen waren. Im Allgemeinen wird die 
Konzentration an IGFBP-3 im Blut durch IGF-1 und GH reguliert, die wiederum beide 
die Synthese und Sekretion von IGFBP-3 induzieren und dadurch die Konzentration 
erhöhen. Übereinstimmend mit diesen Fakten konnten wir erhöhte IGF-1 
Konzentrationen in den Nachkommen der Hochproteinsauen ermitteln, die auch eine 
erhöhte IGFBP-3 Konzentration an dpn 1 aufzeigten. Dieser offensichtliche 
Zusammenhang zwischen IGF-1 und IGFBP-3 unterstützt die Tatsache, dass das 
IGFBP-3 das bedeutendste Bindungsprotein für IGF-1 darstellt und somit die 
Stabilität von IGF-1 im Blut bedingt. 
An keinem der Probennahmetage wurden Unterschiede für das IGF-
Bindungsprotein-4 im Zusammenhang mit der intrauterinen Proteindiät verifiziert. 
Dass das IGFBP-4 die Aktivität des IGF-1 inhibiert, können wir durch unsere 
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Ergebnisse allerdings unterstützen, da wir eine sehr hohe negative Korrelation 
zwischen IGFBP-4 und IGF-1 an allen Probennahmetagen zeigen konnten.  
 
Als letzter Teil des IGF-Systems und als wichtigster Zielrezeptor, wurde der IGF-1 
Rezeptor (IGF-1R) in Lebergewebe mit Hilfe eines kommerziell erhältlichen ELISA 
für den Nachweis von humanem IGF-1R herangezogen, wobei dieser vorher 
ebenfalls ausführlich auf seine Funktionalität für porcine Leberproben geprüft wurde. 
Der IGF-1R konnte nur in den Leberproben der Föten (dpc 94) nachgewiesen 
werden. Weder die maternale Fütterungsgruppe, noch das fötale Geburtsgewicht, die 
Wurfgruppengröße oder das Geschlecht beeinflussten offensichtlich den IGF-1 
Rezeptor zu diesem Zeitpunkt. Diese Feststellung deutet darauf hin, dass 
unterschiedliche Proteindiäten während der ganzen Trächtigkeit, wenn überhaupt, 
dann wahrscheinlich hauptsächlich auf der Ebene der Liganden und nicht auf der 
Ebene der Rezeptoren wirken, vorausgesetzt das IGF-System ist überhaupt 
betroffen.  
 
Zusätzlich wurden in dieser Arbeit auch die Körpergewichte ermittelt und einzelne 
Komponenten der Körperzusammensetzung der Nachkommen durch eine 
chemische Analyse des Schlachtkörpers untersucht. Beide wurden durch die 
inadäquate Proteinversorgung während der Trächtigkeit beeinflusst. An dpn 1 wiesen 
die Ferkel der Niedrigproteinsauen niedrigere Körper- und Schlachtgewichte im 
Vergleich zu den Nachkommen der Adäquatproteinsauen auf. In Übereinstimmung 
damit zeigten Ferkel der leichteren Geburtsgewichtsklasse, die hauptsächlich 
Nachkommen der Niedrigproteinsauen waren, ebenso niedrigere Schlachtgewichte. 
Als potentiellen Grund für das beeinträchtigte fötale Wachstum, resultierend in 
reduzierten Geburtsgewichten, wird das Defizit an vor allem essentiellen 
Aminosäuren, begründet durch die Unterversorgung mit Protein während der 
Trächtigkeit, angesehen. Neben essentiellen Aminosäuren könnten auch veränderte 
Konzentrationen anderer Hormone, wie zum Beispiel Insulin, Leptin und IGF-1 eine 
zusätzliche Begründung für die fötale Wachstumsretardierung in den Nachkommen 
der Sauen, die während ihrer Trächtigkeit proteinrestriktiv ernährt wurden, darstellen. 
Diese Hypothese wird teilweise durch die Andeutung einer Beziehung zwischen dem 
reduzierten Geburtsgewicht und den sinkenden Leptin- und IGF-1-Konzentration an 
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dpn 1 in den Nachkommen der Niedrigproteinsauen unterstützt. Die maternale 
Niedrigproteindiät hatte jedoch keinen Einfluss auf das Schlachtgewicht der Tiere an 
dpn 28 oder 188, was wiederum zeigt, dass ein reduziertes Geburtsgewicht, wie in 
den Nachkommen der Niedrigproteinsauen, im postnatalen Leben kompensiert 
werden konnte. 
 
Zusammenfassend zeigen die Ergebnisse unserer Studie deutlich, dass alle durch 
die modifizierten Proteindiäten begründeten, erkennbaren Effekte ausschließlich auf 
die pränatalen und die frühen postnatalen Entwicklungsstadien der Nachkommen 
limitiert waren. Desweiteren lassen sich die nachweisbaren Effekte weitestgehend 
auf die intrauterine Proteinrestriktion zurückführen. Intrauteriner Proteinüberschuss 
hatte hingegen keinen bzw. kaum Einfluss, weder kurzzeitig noch längerfristig, auf 
alle in unserer Studie getesteten Faktoren. Es kann darüber spekuliert werden, ob 
die nicht vorhandenen, aber möglicherweise erwarteten Effekte durch das Umsetzen 
der intrauterin beeinträchtigten Ferkel zu Ammensauen direkt nach der Geburt 
begründbar sind. Diese Hypothese würde in einer Art Nachholvermögen gründen, die 
es den Nachkommen ermöglicht, die vorher beeinträchtigte endokrine und 
körperliche Situation durch eine Adaption an eine veränderte adäquate 
Nährstoffumgebung während ihrer postnatalen Entwicklung zu kompensieren. 
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